| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.578 | 0.01 | 0.578 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.44 0.068 CHEMBL71733 0.407 0.094 CHEMBL3542327 0.42 0.083 CHEMBL3542314 0.398 0.102 CHEMBL3542326 | ||
| 0.577 | 0.014 | 0.577 | 5 Hydroxytryptamine release inhibitor | 0.388 0.086 CHEMBL71733 0.389 0.085 CHEMBL3542327 0.369 0.1 CHEMBL3542314 0.359 0.108 CHEMBL3542326 | ||
| 0.546 | 0.004 | 0.546 | Histone deacetylase class III inhibitor | 0.295 0.005 CHEMBL71733 0.258 0.009 CHEMBL3542327 0.265 0.008 CHEMBL3542314 0.148 0.045 CHEMBL3542326 | ||
| 0.542 | 0.003 | 0.542 | Histone deacetylase SIRT2 inhibitor | 0.275 0.004 CHEMBL71733 0.248 0.004 CHEMBL3542327 0.242 0.004 CHEMBL3542314 0.085 0.041 CHEMBL3542326 | ||
| 0.55 | 0.014 | 0.55 | GABA C receptor rho-3 antagonist | 0.51 0.023 CHEMBL71733 0.384 0.069 CHEMBL3542327 0.511 0.023 CHEMBL3542314 0.522 0.02 CHEMBL3542326 | ||
| 0.502 | 0.018 | 0.502 | MAP kinase kinase 6 inhibitor | 0.329 0.109 CHEMBL71733 0.451 0.034 CHEMBL3542327 0.266 0.17 CHEMBL3542314 0.25 0.19 CHEMBL3542326 | ||
| 0.491 | 0.01 | 0.491 | Peroxidase inhibitor | 0.274 0.042 CHEMBL71733 0.294 0.038 CHEMBL3542327 0.374 0.024 CHEMBL3542314 0.182 0.064 CHEMBL3542326 | ||
| 0.463 | 0.011 | 0.463 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.353 0.027 CHEMBL71733 0.139 0.123 CHEMBL3542327 0.213 0.069 CHEMBL3542314 0.308 0.041 CHEMBL3542326 | ||
| 0.47 | 0.027 | 0.47 | Aryl hydrocarbon receptor agonist | 0.336 0.051 CHEMBL71733 0.24 0.083 CHEMBL3542327 0.372 0.043 CHEMBL3542314 0.175 0.117 CHEMBL3542326 | ||
| 0.477 | 0.037 | 0.477 | Histamine release inhibitor | 0.391 0.08 CHEMBL71733 0.227 0.174 CHEMBL3542327 0.339 0.105 CHEMBL3542314 0.329 0.109 CHEMBL3542326 | ||
| 0.442 | 0.003 | 0.516 | Nitric-oxide synthase stimulant | 0.265 0.023 CHEMBL71733 0.516 0.002 CHEMBL3542327 0.243 0.037 CHEMBL3542314 0.194 0.099 CHEMBL3542326 | CHEMBL3542327 | |
| 0.443 | 0.011 | 0.443 | Death-associated protein kinase 3 inhibitor | 0.152 0.119 CHEMBL71733 | ||
| 0.44 | 0.02 | 0.44 | Superoxide dismutase inhibitor | 0.238 0.082 CHEMBL71733 0.24 0.081 CHEMBL3542327 0.184 0.137 CHEMBL3542314 0.238 0.082 CHEMBL3542326 | ||
| 0.413 | 0.004 | 0.413 | Histone deacetylase SIRT1 inhibitor | 0.27 0.013 CHEMBL71733 0.259 0.015 CHEMBL3542327 0.252 0.017 CHEMBL3542314 0.144 0.067 CHEMBL3542326 | ||
| 0.401 | 0.004 | 0.401 | Check point kinase 2 inhibitor | 0.248 0.01 CHEMBL71733 0.249 0.01 CHEMBL3542327 0.231 0.012 CHEMBL3542314 0.163 0.028 CHEMBL3542326 | ||
| 0.387 | 0.003 | 0.387 | MAP kinase kinase 3 inhibitor | 0.298 0.008 CHEMBL71733 0.292 0.009 CHEMBL3542327 0.277 0.014 CHEMBL3542314 0.274 0.015 CHEMBL3542326 | ||
| 0.378 | 0.01 | 0.378 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.118 0.103 CHEMBL71733 0.121 0.101 CHEMBL3542327 | ||
| 0.377 | 0.01 | 0.377 | Protein kinase (CK1) inhibitor | 0.16 0.06 CHEMBL71733 0.142 0.074 CHEMBL3542314 | ||
| 0.377 | 0.013 | 0.377 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.161 0.109 CHEMBL3542314 | ||
| 0.378 | 0.015 | 0.501 | MAP kinase kinase 2 inhibitor | 0.379 0.015 CHEMBL71733 0.202 0.08 CHEMBL3542327 0.501 0.005 CHEMBL3542314 0.299 0.035 CHEMBL3542326 | CHEMBL3542314 | |
| 0.383 | 0.02 | 0.383 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.361 0.024 CHEMBL71733 0.174 0.076 CHEMBL3542314 0.381 0.021 CHEMBL3542326 | ||
| 0.362 | 0.008 | 0.415 | Heat shock protein 90 alpha antagonist | 0.296 0.015 CHEMBL71733 0.415 0.005 CHEMBL3542327 0.283 0.018 CHEMBL3542314 0.236 0.032 CHEMBL3542326 | CHEMBL3542327 | |
| 0.354 | 0.004 | 0.354 | Porphobilinogen synthase inhibitor | 0.119 0.028 CHEMBL71733 0.156 0.019 CHEMBL3542327 0.167 0.017 CHEMBL3542314 0.118 0.029 CHEMBL3542326 | ||
| 0.372 | 0.029 | 0.443 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.443 0.014 CHEMBL71733 0.32 0.051 CHEMBL3542314 0.32 0.051 CHEMBL3542326 | CHEMBL71733 | |
| 0.364 | 0.034 | 0.364 | Dyrk kinase inhibitor | |||
| 0.352 | 0.024 | 0.352 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.159 0.132 CHEMBL71733 | ||
| 0.343 | 0.022 | 0.343 | CDC-like kinase 2 inhibitor | 0.123 0.116 CHEMBL3542314 | ||
| 0.347 | 0.026 | 0.374 | 5 Hydroxytryptamine uptake stimulant | 0.374 0.019 CHEMBL71733 0.26 0.072 CHEMBL3542327 0.314 0.038 CHEMBL3542314 0.313 0.039 CHEMBL3542326 | CHEMBL71733 | |
| 0.354 | 0.035 | 0.354 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.329 | 0.013 | 0.329 | Protein kinase (CK1) gamma 3 inhibitor | 0.128 0.116 CHEMBL71733 0.132 0.111 CHEMBL3542326 | ||
| 0.333 | 0.018 | 0.333 | Protein kinase C nu inhibitor | 0.135 0.079 CHEMBL71733 | ||
| 0.32 | 0.008 | 0.32 | GABA C receptor agonist | 0.193 0.022 CHEMBL71733 0.221 0.017 CHEMBL3542327 0.169 0.028 CHEMBL3542314 0.165 0.029 CHEMBL3542326 | ||
| 0.321 | 0.017 | 0.321 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.315 | 0.012 | 0.315 | Growth factor agonist | 0.151 0.138 CHEMBL71733 0.175 0.094 CHEMBL3542327 | ||
| 0.302 | 0.005 | 0.302 | Glutamate receptor agonist | 0.165 0.015 CHEMBL71733 0.068 0.065 CHEMBL3542327 0.118 0.027 CHEMBL3542314 | ||
| 0.306 | 0.01 | 0.306 | 3C-like protease (Human coronavirus) inhibitor | 0.174 0.07 CHEMBL71733 0.169 0.075 CHEMBL3542327 0.158 0.089 CHEMBL3542314 0.144 0.112 CHEMBL3542326 | ||
| 0.333 | 0.04 | 0.333 | Transcription factor STAT inhibitor | 0.245 0.09 CHEMBL71733 0.231 0.101 CHEMBL3542327 0.21 0.124 CHEMBL3542314 0.306 0.053 CHEMBL3542326 | ||
| 0.304 | 0.013 | 0.304 | I kappa B kinase epsilon inhibitor | 0.23 0.049 CHEMBL71733 0.168 0.101 CHEMBL3542327 0.2 0.071 CHEMBL3542314 0.155 0.114 CHEMBL3542326 | ||
| 0.3 | 0.01 | 0.338 | Heat shock protein 90 antagonist | 0.248 0.021 CHEMBL71733 0.338 0.006 CHEMBL3542327 0.223 0.029 CHEMBL3542314 0.202 0.037 CHEMBL3542326 | CHEMBL3542327 | |
| 0.304 | 0.018 | 0.304 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.26 0.028 CHEMBL71733 0.127 0.079 CHEMBL3542314 0.236 0.036 CHEMBL3542326 | ||
| 0.317 | 0.032 | 0.34 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.285 0.04 CHEMBL71733 0.155 0.122 CHEMBL3542314 0.34 0.025 CHEMBL3542326 | CHEMBL3542326 | |
| 0.328 | 0.043 | 0.351 | Insulysin inhibitor | 0.29 0.065 CHEMBL71733 0.351 0.034 CHEMBL3542327 0.332 0.041 CHEMBL3542314 0.24 0.106 CHEMBL3542326 | CHEMBL3542327 | |
| 0.288 | 0.004 | 0.288 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.227 0.009 CHEMBL71733 0.203 0.017 CHEMBL3542327 0.212 0.013 CHEMBL3542314 0.201 0.018 CHEMBL3542326 | ||
| 0.292 | 0.009 | 0.292 | Cyclin-dependent kinase 8 inhibitor | 0.209 0.03 CHEMBL71733 0.187 0.045 CHEMBL3542327 0.189 0.044 CHEMBL3542314 0.134 0.097 CHEMBL3542326 | ||
| 0.312 | 0.036 | 0.312 | Clk dual-specificity kinase inhibitor | |||
| 0.288 | 0.02 | 0.394 | Tumour necrosis factor antagonist | 0.17 0.076 CHEMBL71733 0.394 0.007 CHEMBL3542327 0.159 0.089 CHEMBL3542314 0.179 0.068 CHEMBL3542326 | CHEMBL3542327 | |
| 0.272 | 0.005 | 0.272 | Glutamate (mGluR) agonist | 0.122 0.018 CHEMBL71733 0.074 0.034 CHEMBL3542314 | ||
| 0.268 | 0.005 | 0.268 | GABA C receptor antagonist | 0.192 0.014 CHEMBL71733 0.169 0.021 CHEMBL3542327 0.184 0.017 CHEMBL3542314 0.169 0.021 CHEMBL3542326 | ||
| 0.267 | 0.004 | 0.267 | GABA C receptor rho-1 antagonist | 0.206 0.007 CHEMBL71733 0.17 0.014 CHEMBL3542327 0.2 0.008 CHEMBL3542314 0.191 0.009 CHEMBL3542326 | ||
| 0.266 | 0.004 | 0.283 | Biliverdin reductase inhibitor | 0.195 0.006 CHEMBL71733 0.234 0.004 CHEMBL3542327 0.283 0.004 CHEMBL3542314 0.089 0.022 CHEMBL3542326 | CHEMBL3542314 | |
| 0.326 | 0.068 | 0.326 | Calcium channel activator | 0.212 0.195 CHEMBL71733 0.232 0.169 CHEMBL3542327 | ||
| 0.29 | 0.036 | 0.318 | 5 Hydroxytryptamine 1E antagonist | 0.318 0.02 CHEMBL71733 0.231 0.096 CHEMBL3542327 0.27 0.054 CHEMBL3542314 0.286 0.04 CHEMBL3542326 | CHEMBL71733 | |
| 0.28 | 0.026 | 0.28 | LIM domain kinase 1 inhibitor | 0.162 0.087 CHEMBL71733 0.144 0.104 CHEMBL3542314 0.151 0.096 CHEMBL3542326 | ||
| 0.297 | 0.044 | 0.297 | Ca(v)3.3 blocker | |||
| 0.327 | 0.075 | 0.327 | Cholesterol antagonist | 0.237 0.135 CHEMBL3542327 | ||
| 0.289 | 0.039 | 0.289 | EphB2 antagonist | 0.151 0.128 CHEMBL71733 | ||
| 0.282 | 0.035 | 0.282 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.218 0.12 CHEMBL71733 0.215 0.126 CHEMBL3542314 | ||
| 0.254 | 0.007 | 0.254 | Activin receptor-like kinase 4 inhibitor | 0.129 0.042 CHEMBL71733 0.11 0.067 CHEMBL3542314 | ||
| 0.27 | 0.025 | 0.27 | Protein kinase (CK1) gamma inhibitor | |||
| 0.251 | 0.006 | 0.251 | MAP kinase kinase 5 inhibitor | 0.217 0.018 CHEMBL71733 0.19 0.045 CHEMBL3542327 0.196 0.037 CHEMBL3542314 0.191 0.044 CHEMBL3542326 | ||
| 0.282 | 0.04 | 0.282 | MAP-kinase-activated kinase 5 inhibitor | 0.2 0.103 CHEMBL71733 0.217 0.084 CHEMBL3542314 | ||
| 0.332 | 0.092 | 0.885 | Toll-Like receptor 7 agonist | 0.885 0.004 CHEMBL3542327 0.23 0.167 CHEMBL3542314 | CHEMBL3542327 | |
| 0.331 | 0.092 | 0.883 | Toll-Like receptor agonist | 0.883 0.004 CHEMBL3542327 0.23 0.167 CHEMBL3542314 | CHEMBL3542327 | |
| 0.242 | 0.005 | 0.242 | CYP2A6 inhibitor | 0.134 0.021 CHEMBL71733 0.073 0.056 CHEMBL3542327 0.073 0.055 CHEMBL3542314 0.105 0.033 CHEMBL3542326 | ||
| 0.281 | 0.047 | 0.281 | Tyrosine kinase inhibitor | 0.118 0.11 CHEMBL71733 0.189 0.073 CHEMBL3542314 0.148 0.09 CHEMBL3542326 | ||
| 0.318 | 0.084 | 0.405 | Angiogenesis inhibitor | 0.207 0.162 CHEMBL71733 0.219 0.149 CHEMBL3542327 0.405 0.052 CHEMBL3542326 | CHEMBL3542326 | |
| 0.256 | 0.022 | 0.256 | Polo-like kinase-3 inhibitor | 0.201 0.045 CHEMBL71733 0.161 0.073 CHEMBL3542314 0.189 0.051 CHEMBL3542326 | ||
| 0.253 | 0.02 | 0.253 | Cyclin-dependent kinase 7 inhibitor | 0.12 0.084 CHEMBL71733 0.218 0.028 CHEMBL3542327 | ||
| 0.273 | 0.04 | 0.273 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.145 0.099 CHEMBL3542326 | ||
| 0.257 | 0.024 | 0.257 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.213 0.036 CHEMBL3542327 | ||
| 0.271 | 0.04 | 0.271 | TRKC antagonist | 0.204 0.065 CHEMBL71733 0.163 0.091 CHEMBL3542314 0.236 0.053 CHEMBL3542326 | ||
| 0.241 | 0.01 | 0.241 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.081 0.049 CHEMBL71733 0.092 0.041 CHEMBL3542327 0.07 0.061 CHEMBL3542314 | ||
| 0.233 | 0.005 | 0.233 | I kappa B kinase 1 inhibitor | 0.091 0.028 CHEMBL71733 0.073 0.044 CHEMBL3542327 0.08 0.037 CHEMBL3542314 | ||
| 0.267 | 0.04 | 0.267 | CDC-like kinase 4 inhibitor | |||
| 0.233 | 0.006 | 0.43 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.11 0.025 CHEMBL71733 0.191 0.009 CHEMBL3542327 0.135 0.018 CHEMBL3542314 0.43 0.004 CHEMBL3542326 | CHEMBL3542326 | |
| 0.236 | 0.015 | 0.372 | Ferrochelatase inhibitor | 0.235 0.015 CHEMBL71733 0.147 0.039 CHEMBL3542327 0.372 0.004 CHEMBL3542314 0.153 0.036 CHEMBL3542326 | CHEMBL3542314 | |
| 0.224 | 0.005 | 0.224 | Alcohol oxidase inhibitor | 0.081 0.024 CHEMBL71733 0.122 0.014 CHEMBL3542327 0.126 0.013 CHEMBL3542314 0.061 0.035 CHEMBL3542326 | ||
| 0.261 | 0.044 | 0.261 | Peptidyltransferase inhibitor | 0.245 0.054 CHEMBL71733 0.217 0.079 CHEMBL3542327 0.232 0.065 CHEMBL3542314 0.225 0.071 CHEMBL3542326 | ||
| 0.228 | 0.021 | 0.228 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.115 0.074 CHEMBL71733 0.125 0.064 CHEMBL3542327 | ||
| 0.297 | 0.09 | 0.297 | Antithrombotic | 0.233 0.14 CHEMBL71733 0.271 0.11 CHEMBL3542327 0.2 0.177 CHEMBL3542314 | ||
| 0.228 | 0.021 | 0.228 | Abl kinase inhibitor | 0.114 0.073 CHEMBL71733 0.125 0.064 CHEMBL3542327 | ||
| 0.217 | 0.01 | 0.221 | Alcohol dehydrogenase inhibitor | 0.221 0.01 CHEMBL71733 0.12 0.035 CHEMBL3542327 0.2 0.012 CHEMBL3542314 0.119 0.035 CHEMBL3542326 | CHEMBL71733 | |
| 0.228 | 0.022 | 0.241 | Aldehyde dehydrogenase inhibitor | 0.153 0.045 CHEMBL71733 0.115 0.077 CHEMBL3542327 0.241 0.019 CHEMBL3542314 0.102 0.094 CHEMBL3542326 | CHEMBL3542314 | |
| 0.23 | 0.024 | 0.23 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.269 | 0.065 | 0.285 | Interleukin agonist | 0.266 0.067 CHEMBL71733 0.235 0.09 CHEMBL3542327 0.242 0.085 CHEMBL3542314 0.285 0.056 CHEMBL3542326 | CHEMBL3542326 | |
| 0.221 | 0.019 | 0.221 | GABA C receptor rho-2 antagonist | 0.184 0.039 CHEMBL71733 0.142 0.084 CHEMBL3542327 0.184 0.039 CHEMBL3542314 0.183 0.04 CHEMBL3542326 | ||
| 0.222 | 0.021 | 0.317 | MAP kinase kinase inhibitor | 0.221 0.022 CHEMBL71733 0.115 0.079 CHEMBL3542327 0.317 0.007 CHEMBL3542314 0.156 0.048 CHEMBL3542326 | CHEMBL3542314 | |
| 0.26 | 0.059 | 0.281 | Tyrosine 3 hydroxylase inhibitor | 0.281 0.043 CHEMBL71733 0.25 0.068 CHEMBL3542327 0.263 0.057 CHEMBL3542314 0.273 0.049 CHEMBL3542326 | CHEMBL71733 | |
| 0.207 | 0.006 | 0.207 | Death-associated protein kinase 1 inhibitor | |||
| 0.204 | 0.007 | 0.204 | I kappa B kinase inhibitor | 0.116 0.028 CHEMBL71733 0.087 0.051 CHEMBL3542314 | ||
| 0.239 | 0.043 | 0.239 | Focal adhesion kinase 2 inhibitor | 0.163 0.111 CHEMBL71733 0.184 0.083 CHEMBL3542314 0.163 0.111 CHEMBL3542326 | ||
| 0.202 | 0.007 | 0.202 | Transcription factor STAT6 inhibitor | 0.181 0.01 CHEMBL71733 0.127 0.049 CHEMBL3542327 0.132 0.041 CHEMBL3542314 0.147 0.025 CHEMBL3542326 | ||
| 0.2 | 0.005 | 0.2 | CDC7 inhibitor | 0.083 0.034 CHEMBL71733 0.062 0.054 CHEMBL3542327 0.067 0.048 CHEMBL3542314 | ||
| 0.211 | 0.016 | 0.211 | CF transmembrane conductance regulator agonist | 0.164 0.055 CHEMBL71733 0.172 0.044 CHEMBL3542327 0.153 0.07 CHEMBL3542314 0.19 0.028 CHEMBL3542326 | ||
| 0.217 | 0.024 | 0.217 | Protein kinase (CK1) delta inhibitor | |||
| 0.289 | 0.096 | 0.292 | Vasodilator, coronary | 0.292 0.094 CHEMBL3542327 | CHEMBL3542327 | |
| 0.238 | 0.046 | 0.238 | Neurotrophic factor enhancer | 0.167 0.114 CHEMBL71733 | ||
| 0.22 | 0.029 | 0.22 | Activin receptor-like kinase 2 inhibitor | 0.153 0.065 CHEMBL71733 0.204 0.035 CHEMBL3542314 | ||
| 0.193 | 0.004 | 0.193 | Glutamate (mGluR group I) agonist | 0.081 0.012 CHEMBL71733 0.045 0.037 CHEMBL3542327 0.094 0.009 CHEMBL3542314 | ||
| 0.242 | 0.054 | 0.275 | RNA-directed DNA polymerase inhibitor | 0.275 0.038 CHEMBL71733 0.185 0.123 CHEMBL3542327 0.204 0.094 CHEMBL3542314 0.245 0.052 CHEMBL3542326 | CHEMBL71733 | |
| 0.208 | 0.02 | 0.208 | Granulocyte macrophage colony stimulating factor antagonist | 0.127 0.048 CHEMBL71733 0.192 0.024 CHEMBL3542327 0.163 0.032 CHEMBL3542314 0.131 0.046 CHEMBL3542326 | ||
| 0.212 | 0.028 | 0.212 | Hemostatic | 0.144 0.076 CHEMBL71733 0.153 0.064 CHEMBL3542327 0.166 0.052 CHEMBL3542314 | ||
| 0.213 | 0.03 | 0.213 | Alpha-N-acetylglucosaminidase inhibitor | 0.158 0.05 CHEMBL71733 0.165 0.047 CHEMBL3542327 0.139 0.062 CHEMBL3542314 0.108 0.09 CHEMBL3542326 | ||
| 0.338 | 0.155 | 0.338 | Caspase 9 stimulant | 0.252 0.251 CHEMBL71733 0.282 0.214 CHEMBL3542314 | ||
| 0.193 | 0.011 | 0.193 | Stem cell growth factor agonist | 0.08 0.066 CHEMBL3542327 | ||
| 0.194 | 0.013 | 0.194 | Rho-associated kinase inhibitor | |||
| 0.194 | 0.015 | 0.194 | Protein kinase C gamma inhibitor | 0.178 0.019 CHEMBL71733 0.108 0.064 CHEMBL3542327 0.162 0.025 CHEMBL3542314 0.139 0.039 CHEMBL3542326 | ||
| 0.189 | 0.013 | 0.189 | Rho-associated kinase II inhibitor | |||
| 0.189 | 0.014 | 0.189 | Protein kinase C mu inhibitor | 0.114 0.045 CHEMBL71733 0.106 0.051 CHEMBL3542314 | ||
| 0.215 | 0.041 | 0.215 | 5 Hydroxytryptamine 3E antagonist | 0.205 0.054 CHEMBL71733 0.191 0.079 CHEMBL3542327 0.195 0.071 CHEMBL3542314 0.193 0.076 CHEMBL3542326 | ||
| 0.198 | 0.024 | 0.198 | MAP kinase 3 inhibitor | 0.156 0.059 CHEMBL71733 0.165 0.048 CHEMBL3542314 0.133 0.099 CHEMBL3542326 | ||
| 0.258 | 0.085 | 0.3 | 5 Hydroxytryptamine release stimulant | 0.3 0.07 CHEMBL71733 0.247 0.09 CHEMBL3542314 0.27 0.08 CHEMBL3542326 | CHEMBL71733 | |
| 0.179 | 0.006 | 0.179 | Janus tyrosine kinase 1 inhibitor | 0.096 0.023 CHEMBL71733 0.077 0.03 CHEMBL3542314 | ||
| 0.184 | 0.014 | 0.184 | Janus tyrosine kinase 2 inhibitor | 0.076 0.051 CHEMBL71733 | ||
| 0.177 | 0.007 | 0.177 | Acetylcholine release stimulant | 0.128 0.037 CHEMBL71733 0.106 0.074 CHEMBL3542314 | ||
| 0.177 | 0.008 | 0.217 | MAP kinase kinase 1 inhibitor | 0.19 0.005 CHEMBL71733 0.115 0.039 CHEMBL3542327 0.217 0.004 CHEMBL3542314 0.171 0.01 CHEMBL3542326 | CHEMBL3542314 | |
| 0.186 | 0.019 | 0.186 | MAP kinase 8 inhibitor | 0.106 0.054 CHEMBL3542314 | ||
| 0.171 | 0.006 | 0.171 | Histone deacetylase SIRT1 stimulant | 0.08 0.044 CHEMBL71733 0.064 0.063 CHEMBL3542314 | ||
| 0.171 | 0.006 | 0.171 | Histone deacetylase stimulant | 0.08 0.044 CHEMBL71733 0.064 0.063 CHEMBL3542314 | ||
| 0.174 | 0.01 | 0.174 | Polo-like kinase-1 inhibitor | 0.174 0.01 CHEMBL71733 0.148 0.017 CHEMBL3542327 0.159 0.014 CHEMBL3542314 0.167 0.012 CHEMBL3542326 | ||
| 0.22 | 0.058 | 0.296 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.241 0.047 CHEMBL71733 0.296 0.025 CHEMBL3542327 0.182 0.09 CHEMBL3542314 0.246 0.044 CHEMBL3542326 | CHEMBL3542327 | |
| 0.213 | 0.051 | 0.246 | Histone acetyltransferase inhibitor | 0.179 0.101 CHEMBL71733 0.199 0.071 CHEMBL3542327 0.246 0.027 CHEMBL3542314 | CHEMBL3542314 | |
| 0.169 | 0.008 | 0.169 | Amidase inhibitor | 0.095 0.027 CHEMBL71733 0.104 0.022 CHEMBL3542327 0.106 0.021 CHEMBL3542314 | ||
| 0.183 | 0.022 | 0.183 | MAP kinase kinase 4 inhibitor | |||
| 0.259 | 0.1 | 0.405 | Nootropic | 0.405 0.037 CHEMBL71733 0.196 0.163 CHEMBL3542327 0.369 0.048 CHEMBL3542314 0.185 0.179 CHEMBL3542326 | CHEMBL71733 | |
| 0.191 | 0.033 | 0.191 | Sodium channel (voltage-gated) blocker | 0.126 0.078 CHEMBL71733 0.156 0.05 CHEMBL3542314 | ||
| 0.194 | 0.037 | 0.194 | Nav1.2 sodium channel blocker | 0.126 0.077 CHEMBL71733 0.109 0.097 CHEMBL3542314 | ||
| 0.169 | 0.013 | 0.169 | DOPA decarboxylase inhibitor | 0.119 0.046 CHEMBL71733 0.145 0.024 CHEMBL3542327 0.11 0.058 CHEMBL3542314 0.119 0.046 CHEMBL3542326 | ||
| 0.188 | 0.034 | 0.188 | TRKA antagonist | 0.113 0.074 CHEMBL71733 0.169 0.04 CHEMBL3542314 | ||
| 0.158 | 0.004 | 0.158 | Histone deacetylase SIRT3 inhibitor | 0.09 0.013 CHEMBL71733 0.082 0.017 CHEMBL3542327 0.077 0.02 CHEMBL3542314 0.07 0.027 CHEMBL3542326 | ||
| 0.162 | 0.01 | 0.162 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 CHEMBL71733 0.08 0.038 CHEMBL3542327 0.06 0.058 CHEMBL3542314 | ||
| 0.188 | 0.037 | 0.188 | Sodium channel blocker | 0.115 0.091 CHEMBL71733 0.144 0.062 CHEMBL3542314 | ||
| 0.16 | 0.014 | 0.16 | Interleukin 2 antagonist | 0.141 0.023 CHEMBL71733 0.108 0.069 CHEMBL3542314 | ||
| 0.159 | 0.014 | 0.164 | Glutamate dehydrogenase inhibitor | 0.11 0.026 CHEMBL71733 0.118 0.023 CHEMBL3542327 0.164 0.014 CHEMBL3542314 0.093 0.035 CHEMBL3542326 | CHEMBL3542314 | |
| 0.171 | 0.027 | 0.185 | MAP kinase kinase kinase inhibitor | 0.107 0.06 CHEMBL71733 0.185 0.022 CHEMBL3542327 0.089 0.077 CHEMBL3542314 | CHEMBL3542327 | |
| 0.214 | 0.074 | 0.214 | Pyruvate kinase inhibitor | 0.183 0.091 CHEMBL71733 0.196 0.083 CHEMBL3542327 0.152 0.114 CHEMBL3542314 | ||
| 0.157 | 0.019 | 0.157 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.092 0.054 CHEMBL71733 0.081 0.07 CHEMBL3542327 0.094 0.052 CHEMBL3542314 | ||
| 0.231 | 0.092 | 0.384 | DNA damaging | 0.352 0.04 CHEMBL71733 0.33 0.047 CHEMBL3542327 0.249 0.081 CHEMBL3542314 0.384 0.032 CHEMBL3542326 | CHEMBL3542326 | |
| 0.183 | 0.045 | 0.183 | Ribosomal protein S6 kinase inhibitor | |||
| 0.141 | 0.003 | 0.141 | Protein kinase (CK1) epsilon inhibitor | 0.066 0.007 CHEMBL71733 0.041 0.023 CHEMBL3542327 0.056 0.01 CHEMBL3542314 0.04 0.026 CHEMBL3542326 | ||
| 0.151 | 0.014 | 0.151 | Toll-Like receptor 3 antagonist | 0.091 0.066 CHEMBL71733 | ||
| 0.178 | 0.041 | 0.251 | Cell wall synthesis inhibitor | 0.251 0.016 CHEMBL71733 0.132 0.084 CHEMBL3542327 0.185 0.037 CHEMBL3542314 0.242 0.018 CHEMBL3542326 | CHEMBL71733 | |
| 0.183 | 0.046 | 0.183 | CDC-like kinase 1 inhibitor | |||
| 0.155 | 0.021 | 0.372 | Phosphodiesterase IV inhibitor | 0.372 0.004 CHEMBL3542327 0.081 0.06 CHEMBL3542314 | CHEMBL3542327 | |
| 0.146 | 0.013 | 0.146 | Lanosterol 14 alpha demethylase inhibitor | 0.084 0.083 CHEMBL71733 0.087 0.078 CHEMBL3542327 | ||
| 0.152 | 0.02 | 0.152 | Protein kinase C delta inhibitor | |||
| 0.16 | 0.028 | 0.17 | Heat shock protein 70 antagonist | 0.17 0.018 CHEMBL71733 0.13 0.122 CHEMBL3542327 0.148 0.049 CHEMBL3542314 0.151 0.043 CHEMBL3542326 | CHEMBL71733 | |
| 0.155 | 0.024 | 0.155 | Nav1.5 sodium channel blocker | 0.131 0.042 CHEMBL71733 0.112 0.065 CHEMBL3542314 | ||
| 0.149 | 0.017 | 0.149 | Acetylcholine nicotinic agonist | 0.086 0.049 CHEMBL71733 0.094 0.042 CHEMBL3542327 0.093 0.043 CHEMBL3542314 | ||
| 0.146 | 0.015 | 0.146 | Keratolytic | 0.099 0.031 CHEMBL3542327 | ||
| 0.189 | 0.058 | 0.196 | Succinate dehydrogenase inhibitor | 0.171 0.079 CHEMBL71733 0.175 0.074 CHEMBL3542327 0.196 0.052 CHEMBL3542314 0.168 0.084 CHEMBL3542326 | CHEMBL3542314 | |
| 0.136 | 0.006 | 0.136 | I kappa B kinase 2 inhibitor | 0.079 0.023 CHEMBL71733 0.065 0.039 CHEMBL3542314 | ||
| 0.178 | 0.049 | 0.178 | Glycogen synthase kinase-3 alpha inhibitor | 0.109 0.094 CHEMBL3542327 0.114 0.09 CHEMBL3542314 | ||
| 0.134 | 0.004 | 0.134 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.098 0.015 CHEMBL71733 0.102 0.012 CHEMBL3542327 0.095 0.017 CHEMBL3542314 0.085 0.028 CHEMBL3542326 | ||
| 0.148 | 0.019 | 0.148 | Pim-3 kinase inhibitor | 0.087 0.063 CHEMBL71733 | ||
| 0.144 | 0.015 | 0.144 | Rho-associated kinase I inhibitor | 0.066 0.062 CHEMBL3542327 | ||
| 0.13 | 0.004 | 0.13 | Exportin-1 inhibitor | 0.074 0.034 CHEMBL71733 0.078 0.029 CHEMBL3542327 0.099 0.009 CHEMBL3542314 | ||
| 0.22 | 0.094 | 0.245 | Calpain inhibitor | 0.245 0.069 CHEMBL3542327 | CHEMBL3542327 | |
| 0.173 | 0.047 | 0.173 | Cytokine production inhibitor | 0.136 0.074 CHEMBL3542314 | ||
| 0.176 | 0.051 | 0.176 | Tyrosine-protein kinase receptor antagonist | 0.112 0.095 CHEMBL71733 0.165 0.056 CHEMBL3542314 | ||
| 0.143 | 0.018 | 0.143 | Bcr-Abl kinase inhibitor | 0.107 0.035 CHEMBL71733 0.103 0.038 CHEMBL3542327 0.086 0.057 CHEMBL3542326 | ||
| 0.183 | 0.058 | 0.183 | Phospholipase C inhibitor | 0.165 0.08 CHEMBL71733 0.175 0.067 CHEMBL3542327 0.174 0.068 CHEMBL3542314 0.143 0.122 CHEMBL3542326 | ||
| 0.128 | 0.005 | 0.128 | Aconitate hydratase inhibitor | 0.068 0.02 CHEMBL71733 0.076 0.015 CHEMBL3542327 0.051 0.037 CHEMBL3542314 | ||
| 0.152 | 0.029 | 0.152 | TRPA1 agonist | |||
| 0.159 | 0.037 | 0.159 | Cystathionine beta-synthase inhibitor | 0.139 0.046 CHEMBL71733 0.15 0.04 CHEMBL3542314 0.129 0.052 CHEMBL3542326 | ||
| 0.175 | 0.053 | 0.175 | NOS3 expression enhancer | |||
| 0.249 | 0.128 | 0.249 | Transcription factor NF kappa B inhibitor | 0.198 0.171 CHEMBL71733 0.233 0.14 CHEMBL3542326 | ||
| 0.178 | 0.057 | 0.178 | Death-associated protein kinase 2 inhibitor | |||
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.169 | 0.048 | 0.169 | Alkaline phosphatase inhibitor | |||
| 0.155 | 0.036 | 0.155 | MAP kinase 9 inhibitor | |||
| 0.202 | 0.083 | 0.202 | Interleukin antagonist | |||
| 0.217 | 0.098 | 0.25 | DNA synthesis inhibitor | 0.242 0.072 CHEMBL71733 0.248 0.068 CHEMBL3542327 0.232 0.081 CHEMBL3542314 0.25 0.066 CHEMBL3542326 | CHEMBL3542326 | |
| 0.145 | 0.026 | 0.145 | Protein kinase A inhibitor | |||
| 0.14 | 0.021 | 0.142 | Histidine decarboxylase inhibitor | 0.073 0.048 CHEMBL71733 0.075 0.046 CHEMBL3542327 0.142 0.021 CHEMBL3542314 0.069 0.051 CHEMBL3542326 | CHEMBL3542314 | |
| 0.132 | 0.016 | 0.132 | Aminopeptidase I inhibitor | 0.098 0.029 CHEMBL71733 0.098 0.029 CHEMBL3542327 0.079 0.043 CHEMBL3542314 0.068 0.056 CHEMBL3542326 | ||
| 0.155 | 0.039 | 0.155 | Vascular endothelial growth factor 1 antagonist | |||
| 0.151 | 0.036 | 0.161 | Falcipain 3 inhibitor | 0.159 0.032 CHEMBL71733 0.161 0.032 CHEMBL3542314 | CHEMBL3542314 | |
| 0.144 | 0.03 | 0.144 | Pim-1 kinase inhibitor | |||
| 0.128 | 0.014 | 0.128 | Nicotinic alpha4beta2 receptor antagonist | 0.115 0.021 CHEMBL71733 0.086 0.044 CHEMBL3542314 | ||
| 0.12 | 0.006 | 0.12 | Poly(ADP-ribose) polymerase inhibitor | 0.071 0.013 CHEMBL71733 0.054 0.02 CHEMBL3542327 0.07 0.013 CHEMBL3542314 | ||
| 0.126 | 0.013 | 0.126 | MAP kinase kinase 8 inhibitor | 0.064 0.056 CHEMBL71733 0.104 0.02 CHEMBL3542314 | ||
| 0.13 | 0.018 | 0.13 | Nav1.8 sodium channel blocker | 0.096 0.03 CHEMBL3542314 | ||
| 0.122 | 0.01 | 0.122 | Transforming growth factor beta 3 antagonist | 0.079 0.067 CHEMBL71733 0.08 0.065 CHEMBL3542326 | ||
| 0.15 | 0.038 | 0.169 | Aminopeptidase B inhibitor | 0.098 0.066 CHEMBL71733 0.169 0.03 CHEMBL3542327 0.126 0.049 CHEMBL3542314 | CHEMBL3542327 | |
| 0.116 | 0.005 | 0.116 | Glutamate (mGluR5) agonist | 0.053 0.023 CHEMBL71733 0.059 0.018 CHEMBL3542314 | ||
| 0.124 | 0.014 | 0.124 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 CHEMBL71733 0.089 0.053 CHEMBL3542327 | ||
| 0.118 | 0.01 | 0.118 | Protein kinase C epsilon inhibitor | 0.05 0.042 CHEMBL71733 | ||
| 0.158 | 0.049 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.106 CHEMBL71733 0.134 0.091 CHEMBL3542314 0.144 0.072 CHEMBL3542326 | ||
| 0.121 | 0.013 | 0.121 | Transforming growth factor antagonist | 0.071 0.046 CHEMBL3542327 | ||
| 0.17 | 0.062 | 0.17 | Neurotensin receptor agonist | 0.165 0.071 CHEMBL71733 0.138 0.135 CHEMBL3542327 0.141 0.125 CHEMBL3542326 | ||
| 0.139 | 0.032 | 0.175 | Gastric antisecretory | 0.1 0.066 CHEMBL71733 0.175 0.018 CHEMBL3542327 | CHEMBL3542327 | |
| 0.149 | 0.042 | 0.149 | Beta amyloid protein antagonist | 0.116 0.071 CHEMBL3542314 | ||
| 0.142 | 0.035 | 0.142 | CC chemokine 6 receptor antagonist | 0.123 0.102 CHEMBL71733 | ||
| 0.294 | 0.187 | 0.294 | MAP kinase 1 inhibitor | |||
| 0.123 | 0.017 | 0.289 | Phosphodiesterase 4B inhibitor | 0.289 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.191 | 0.085 | 0.284 | Psychostimulant | 0.284 0.047 CHEMBL71733 0.22 0.07 CHEMBL3542314 0.228 0.067 CHEMBL3542326 | CHEMBL71733 | |
| 0.118 | 0.014 | 0.122 | MAP3K7 inhibitor | 0.122 0.014 CHEMBL71733 0.075 0.047 CHEMBL3542314 0.098 0.023 CHEMBL3542326 | CHEMBL71733 | |
| 0.111 | 0.008 | 0.111 | Oleamide hydrolase inhibitor | 0.047 0.03 CHEMBL71733 0.042 0.035 CHEMBL3542327 | ||
| 0.128 | 0.025 | 0.128 | Histamine N-methyltransferase inhibitor | 0.099 0.047 CHEMBL71733 0.119 0.03 CHEMBL3542314 | ||
| 0.109 | 0.007 | 0.109 | Glutamate (mGluR7) antagonist | 0.108 0.007 CHEMBL71733 0.076 0.033 CHEMBL3542327 0.103 0.009 CHEMBL3542314 0.091 0.017 CHEMBL3542326 | ||
| 0.142 | 0.04 | 0.142 | MAP kinase 13 inhibitor | |||
| 0.109 | 0.007 | 0.109 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.048 CHEMBL71733 | ||
| 0.115 | 0.014 | 0.115 | Histone deacetylase inhibitor | 0.096 0.02 CHEMBL71733 0.065 0.046 CHEMBL3542327 0.069 0.041 CHEMBL3542314 | ||
| 0.125 | 0.024 | 0.125 | Glutamate (mGluR) antagonist | |||
| 0.13 | 0.029 | 0.145 | Electrolyte absorption antagonist | 0.111 0.044 CHEMBL71733 0.145 0.021 CHEMBL3542314 | CHEMBL3542314 | |
| 0.141 | 0.041 | 0.171 | 5 Hydroxytryptamine 3A agonist | 0.157 0.032 CHEMBL71733 0.148 0.037 CHEMBL3542314 0.171 0.025 CHEMBL3542326 | CHEMBL3542326 | |
| 0.127 | 0.028 | 0.127 | Protein kinase C zeta inhibitor | 0.099 0.052 CHEMBL71733 0.096 0.056 CHEMBL3542314 0.11 0.04 CHEMBL3542326 | ||
| 0.163 | 0.064 | 0.163 | Hexokinase inhibitor | |||
| 0.118 | 0.021 | 0.118 | Tyk2 inhibitor | |||
| 0.099 | 0.005 | 0.099 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.04 0.012 CHEMBL71733 0.027 0.021 CHEMBL3542327 0.035 0.014 CHEMBL3542314 0.028 0.02 CHEMBL3542326 | ||
| 0.129 | 0.036 | 0.143 | Adenylate kinase inhibitor | 0.104 0.062 CHEMBL71733 0.113 0.05 CHEMBL3542327 0.143 0.029 CHEMBL3542314 0.096 0.075 CHEMBL3542326 | CHEMBL3542314 | |
| 0.105 | 0.013 | 0.105 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 CHEMBL71733 0.06 0.034 CHEMBL3542327 0.05 0.048 CHEMBL3542314 | ||
| 0.139 | 0.049 | 0.139 | Protein kinase (CK2) alpha inhibitor | |||
| 0.102 | 0.011 | 0.102 | MAP kinase kinase 7 inhibitor | 0.087 0.029 CHEMBL71733 0.08 0.047 CHEMBL3542327 0.083 0.038 CHEMBL3542314 0.083 0.039 CHEMBL3542326 | ||
| 0.109 | 0.02 | 0.109 | Protein kinase B beta inhibitor | 0.078 0.044 CHEMBL3542327 | ||
| 0.099 | 0.011 | 0.106 | Heat shock protein 90 beta antagonist | 0.106 0.009 CHEMBL71733 0.069 0.029 CHEMBL3542314 0.088 0.016 CHEMBL3542326 | CHEMBL71733 | |
| 0.102 | 0.014 | 0.102 | Phospholipase D inhibitor | 0.074 0.044 CHEMBL71733 0.083 0.03 CHEMBL3542314 | ||
| 0.157 | 0.07 | 0.321 | Cytidine deaminase inhibitor | 0.321 0.016 CHEMBL71733 0.193 0.051 CHEMBL3542314 0.225 0.037 CHEMBL3542326 | CHEMBL71733 | |
| 0.14 | 0.054 | 0.14 | Cathepsin H inhibitor | 0.107 0.094 CHEMBL3542327 0.11 0.089 CHEMBL3542314 | ||
| 0.092 | 0.006 | 0.092 | Glutamate (mGluR4) antagonist | 0.047 0.025 CHEMBL3542327 | ||
| 0.113 | 0.028 | 0.113 | MAP kinase 10 inhibitor | |||
| 0.109 | 0.025 | 0.109 | Protein kinase B alpha inhibitor | |||
| 0.109 | 0.025 | 0.109 | Glutamate decarboxylase inhibitor | 0.074 0.05 CHEMBL71733 0.078 0.046 CHEMBL3542327 0.105 0.027 CHEMBL3542314 0.07 0.054 CHEMBL3542326 | ||
| 0.132 | 0.048 | 0.132 | Interleukin 8 antagonist | 0.102 0.092 CHEMBL71733 0.113 0.072 CHEMBL3542327 | ||
| 0.103 | 0.019 | 0.103 | Glycine receptor agonist | 0.082 0.036 CHEMBL71733 0.072 0.051 CHEMBL3542327 0.095 0.024 CHEMBL3542314 | ||
| 0.144 | 0.059 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.147 0.049 CHEMBL71733 0.136 0.092 CHEMBL3542327 0.146 0.054 CHEMBL3542314 0.141 0.069 CHEMBL3542326 | CHEMBL71733 | |
| 0.188 | 0.104 | 0.277 | Potassium channel (Voltage-sensitive) blocker | 0.245 0.069 CHEMBL71733 0.277 0.057 CHEMBL3542314 | CHEMBL3542314 | |
| 0.105 | 0.021 | 0.105 | Nav1.7 sodium channel blocker | 0.064 0.052 CHEMBL71733 0.069 0.045 CHEMBL3542314 | ||
| 0.105 | 0.022 | 0.105 | Neuronal nicotinic receptor antagonist | 0.099 0.025 CHEMBL71733 0.069 0.046 CHEMBL3542314 | ||
| 0.201 | 0.119 | 0.201 | Spasmolytic | |||
| 0.15 | 0.068 | 0.15 | Thiol protease inhibitor | 0.135 0.087 CHEMBL71733 | ||
| 0.09 | 0.008 | 0.09 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.056 0.014 CHEMBL71733 0.037 0.027 CHEMBL3542327 0.052 0.016 CHEMBL3542314 | ||
| 0.113 | 0.033 | 0.147 | Acetylcholine nicotinic antagonist | 0.147 0.021 CHEMBL71733 0.073 0.063 CHEMBL3542314 0.083 0.051 CHEMBL3542326 | CHEMBL71733 | |
| 0.119 | 0.04 | 0.125 | HIV-1 integrase (Overall Integration) inhibitor | 0.125 0.037 CHEMBL71733 0.086 0.07 CHEMBL3542326 | CHEMBL71733 | |
| 0.138 | 0.058 | 0.138 | Antibacterial (Helicobacter pylori) | 0.108 0.102 CHEMBL71733 0.116 0.088 CHEMBL3542314 | ||
| 0.095 | 0.016 | 0.095 | Protein kinase C beta inhibitor | 0.087 0.022 CHEMBL71733 0.079 0.031 CHEMBL3542314 | ||
| 0.085 | 0.006 | 0.091 | Chemokine receptor agonist | 0.063 0.025 CHEMBL71733 0.091 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.226 | 0.148 | 0.283 | Vasodilator, peripheral | 0.283 0.106 CHEMBL3542327 | CHEMBL3542327 | |
| 0.131 | 0.053 | 0.153 | DNA repair enzyme inhibitor | 0.133 0.05 CHEMBL71733 0.129 0.056 CHEMBL3542327 0.153 0.029 CHEMBL3542314 0.124 0.064 CHEMBL3542326 | CHEMBL3542314 | |
| 0.105 | 0.026 | 0.105 | Check point kinase 1 inhibitor | |||
| 0.083 | 0.005 | 0.083 | Diamine oxidase inhibitor | 0.038 0.026 CHEMBL71733 0.035 0.03 CHEMBL3542314 | ||
| 0.085 | 0.008 | 0.085 | Nicotinamide phosphoribosyltransferase inhibitor | |||
| 0.089 | 0.012 | 0.089 | Transforming growth factor beta 1 antagonist | 0.051 0.033 CHEMBL3542327 | ||
| 0.132 | 0.056 | 0.132 | MAP kinase 12 inhibitor | |||
| 0.106 | 0.031 | 0.106 | Janus tyrosine kinase 3 inhibitor | |||
| 0.112 | 0.037 | 0.128 | Triose-phosphate isomerase inhibitor | 0.087 0.065 CHEMBL71733 0.107 0.041 CHEMBL3542327 0.128 0.028 CHEMBL3542314 0.083 0.071 CHEMBL3542326 | CHEMBL3542314 | |
| 0.144 | 0.069 | 0.144 | Lck kinase inhibitor | |||
| 0.084 | 0.01 | 0.084 | Thromboxane synthase inhibitor | 0.057 0.032 CHEMBL3542327 | ||
| 0.099 | 0.025 | 0.222 | CXC chemokine receptor antagonist | 0.222 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.082 | 0.008 | 0.085 | CXC chemokine 1 receptor antagonist | 0.068 0.014 CHEMBL71733 0.085 0.007 CHEMBL3542327 0.067 0.014 CHEMBL3542314 | CHEMBL3542327 | |
| 0.081 | 0.007 | 0.081 | Glutamate (mGluR group III) antagonist | 0.049 0.022 CHEMBL71733 0.043 0.033 CHEMBL3542327 0.047 0.025 CHEMBL3542314 | ||
| 0.203 | 0.13 | 0.203 | Transcription factor STAT3 inhibitor | 0.175 0.172 CHEMBL3542327 0.186 0.155 CHEMBL3542326 | ||
| 0.15 | 0.077 | 0.15 | Interferon gamma antagonist | |||
| 0.117 | 0.045 | 0.146 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 CHEMBL71733 0.11 0.051 CHEMBL3542327 0.146 0.03 CHEMBL3542314 0.09 0.073 CHEMBL3542326 | CHEMBL3542314 | |
| 0.089 | 0.017 | 0.089 | Nicotinic neuronal receptor agonist | 0.049 0.046 CHEMBL71733 0.062 0.034 CHEMBL3542327 0.055 0.04 CHEMBL3542314 | ||
| 0.086 | 0.014 | 0.1 | Cyclin D1 inhibitor | 0.1 0.008 CHEMBL71733 0.089 0.012 CHEMBL3542314 0.083 0.016 CHEMBL3542326 | CHEMBL71733 | |
| 0.144 | 0.073 | 0.144 | Adenylate cyclase stimulant | |||
| 0.113 | 0.042 | 0.139 | Interleukin 1 beta converting enzyme inhibitor | 0.139 0.022 CHEMBL71733 0.097 0.062 CHEMBL3542314 0.108 0.048 CHEMBL3542326 | CHEMBL71733 | |
| 0.135 | 0.064 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.1 CHEMBL71733 0.127 0.08 CHEMBL3542314 0.135 0.064 CHEMBL3542326 | ||
| 0.092 | 0.021 | 0.092 | Protein kinase C iota inhibitor | |||
| 0.262 | 0.193 | 0.262 | Calcium channel L-type activator | |||
| 0.115 | 0.046 | 0.115 | Insulin receptor antagonist | 0.106 0.054 CHEMBL71733 0.104 0.056 CHEMBL3542326 | ||
| 0.084 | 0.016 | 0.084 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 CHEMBL71733 0.053 0.039 CHEMBL3542314 0.05 0.044 CHEMBL3542326 | ||
| 0.072 | 0.005 | 0.072 | Nerve growth factor antagonist | 0.056 0.012 CHEMBL71733 0.04 0.035 CHEMBL3542327 0.045 0.025 CHEMBL3542314 | ||
| 0.122 | 0.055 | 0.122 | Polo-like kinase-4 inhibitor | |||
| 0.088 | 0.022 | 0.088 | Protease 3C (Human rhinovirus) inhibitor | 0.088 0.022 CHEMBL71733 0.073 0.034 CHEMBL3542327 0.076 0.031 CHEMBL3542314 0.077 0.029 CHEMBL3542326 | ||
| 0.091 | 0.024 | 0.091 | Secretase beta inhibitor | 0.065 0.061 CHEMBL71733 0.066 0.058 CHEMBL3542314 | ||
| 0.074 | 0.008 | 0.093 | Benzodiazepine inverse agonist | 0.06 0.015 CHEMBL71733 0.093 0.005 CHEMBL3542327 0.055 0.019 CHEMBL3542314 0.046 0.033 CHEMBL3542326 | CHEMBL3542327 | |
| 0.083 | 0.017 | 0.083 | Nicotinic alpha7 receptor agonist | 0.051 0.042 CHEMBL71733 0.057 0.035 CHEMBL3542314 | ||
| 0.088 | 0.022 | 0.088 | Potassium channel (ATP-sensitive) blocker | |||
| 0.071 | 0.006 | 0.071 | DNA gyrase subunit B inhibitor | 0.052 0.012 CHEMBL3542314 | ||
| 0.114 | 0.05 | 0.147 | Cyclin-dependent kinase 9 inhibitor | 0.147 0.035 CHEMBL3542327 | CHEMBL3542327 | |
| 0.071 | 0.008 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.061 0.014 CHEMBL71733 0.047 0.038 CHEMBL3542314 0.05 0.029 CHEMBL3542326 | ||
| 0.139 | 0.076 | 0.144 | Vascular endothelial growth factor 3 antagonist | 0.144 0.071 CHEMBL3542326 | CHEMBL3542326 | |
| 0.108 | 0.045 | 0.108 | Glutamate (mGluR7) agonist | |||
| 0.09 | 0.028 | 0.101 | Cyclin A2 inhibitor | 0.074 0.036 CHEMBL71733 0.101 0.024 CHEMBL3542327 0.094 0.027 CHEMBL3542314 | CHEMBL3542327 | |
| 0.103 | 0.041 | 0.113 | NADH dehydrogenase inhibitor | 0.079 0.077 CHEMBL71733 0.113 0.033 CHEMBL3542314 | CHEMBL3542314 | |
| 0.076 | 0.014 | 0.076 | Glutamate (mGluR group III) agonist | |||
| 0.071 | 0.01 | 0.071 | Histamine H2 receptor agonist | 0.043 0.029 CHEMBL71733 0.043 0.03 CHEMBL3542327 | ||
| 0.091 | 0.03 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.065 0.049 CHEMBL71733 | ||
| 0.086 | 0.026 | 0.099 | Carbamoyl phosphate synthetase inhibitor | 0.062 0.041 CHEMBL71733 0.061 0.042 CHEMBL3542327 0.099 0.021 CHEMBL3542314 | CHEMBL3542314 | |
| 0.113 | 0.053 | 0.113 | Protein kinase (CK2) inhibitor | |||
| 0.11 | 0.049 | 0.163 | Creatine kinase inhibitor | 0.109 0.05 CHEMBL71733 0.09 0.071 CHEMBL3542327 0.163 0.019 CHEMBL3542314 0.113 0.047 CHEMBL3542326 | CHEMBL3542314 | |
| 0.134 | 0.075 | 0.134 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.08 | 0.021 | 0.08 | Pim-2 kinase inhibitor | |||
| 0.063 | 0.004 | 0.063 | Glutamate (mGluR1) agonist | 0.028 0.011 CHEMBL71733 0.039 0.005 CHEMBL3542327 0.027 0.012 CHEMBL3542314 | ||
| 0.074 | 0.015 | 0.074 | Epithelial sodium channel blocker | 0.063 0.024 CHEMBL71733 0.052 0.044 CHEMBL3542314 | ||
| 0.093 | 0.034 | 0.093 | Phosphofructokinase-1 inhibitor | 0.064 0.052 CHEMBL3542327 0.063 0.053 CHEMBL3542326 | ||
| 0.13 | 0.071 | 0.13 | Interleukin 4 antagonist | |||
| 0.099 | 0.041 | 0.162 | Bromodomain-containing protein 2 inhibitor | 0.115 0.026 CHEMBL71733 0.162 0.006 CHEMBL3542314 | CHEMBL3542314 | |
| 0.175 | 0.116 | 0.175 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.141 CHEMBL3542314 | ||
| 0.095 | 0.036 | 0.125 | D-Ala-D-Ala ligase inhibitor | 0.125 0.012 CHEMBL71733 0.088 0.049 CHEMBL3542327 0.091 0.043 CHEMBL3542314 0.116 0.015 CHEMBL3542326 | CHEMBL71733 | |
| 0.07 | 0.012 | 0.07 | Sodium/calcium exchanger inhibitor | 0.053 0.028 CHEMBL3542314 | ||
| 0.101 | 0.044 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.176 | 0.119 | 0.176 | Aldehyde oxidase inhibitor | 0.171 0.122 CHEMBL71733 0.16 0.13 CHEMBL3542314 0.168 0.124 CHEMBL3542326 | ||
| 0.078 | 0.021 | 0.078 | Phosphodiesterase 1C inhibitor | 0.059 0.052 CHEMBL3542314 | ||
| 0.114 | 0.057 | 0.114 | Cyclin-dependent kinase 2 inhibitor | 0.094 0.076 CHEMBL3542327 | ||
| 0.105 | 0.049 | 0.137 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.102 0.052 CHEMBL3542327 0.137 0.031 CHEMBL3542314 | CHEMBL3542314 | |
| 0.085 | 0.029 | 0.092 | Cyclin A inhibitor | 0.07 0.037 CHEMBL71733 0.092 0.026 CHEMBL3542327 0.085 0.029 CHEMBL3542314 | CHEMBL3542327 | |
| 0.095 | 0.039 | 0.095 | mTOR complex 2 inhibitor | 0.083 0.06 CHEMBL3542314 | ||
| 0.077 | 0.022 | 0.481 | Phosphodiesterase 4C inhibitor | 0.481 0.003 CHEMBL3542327 | CHEMBL3542327 | |
| 0.088 | 0.033 | 0.107 | Benzodiazepine agonist | 0.07 0.05 CHEMBL71733 0.107 0.022 CHEMBL3542327 0.067 0.056 CHEMBL3542314 0.072 0.048 CHEMBL3542326 | CHEMBL3542327 | |
| 0.064 | 0.011 | 0.064 | Geranyltranstransferase inhibitor | 0.062 0.012 CHEMBL71733 0.042 0.033 CHEMBL3542326 | ||
| 0.123 | 0.071 | 0.143 | Glutamate receptor antagonist | 0.143 0.056 CHEMBL3542327 | CHEMBL3542327 | |
| 0.076 | 0.025 | 0.076 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.06 | 0.008 | 0.06 | Histamine H1 receptor agonist | 0.052 0.015 CHEMBL71733 0.044 0.03 CHEMBL3542327 0.044 0.029 CHEMBL3542314 | ||
| 0.056 | 0.005 | 0.056 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.024 CHEMBL3542327 | ||
| 0.092 | 0.04 | 0.504 | Phosphodiesterase 4D inhibitor | 0.504 0.004 CHEMBL3542327 | CHEMBL3542327 | |
| 0.11 | 0.059 | 0.11 | CDC-like kinase 3 inhibitor | 0.102 0.075 CHEMBL3542314 | ||
| 0.082 | 0.031 | 0.082 | Potassium channel (Tandem pore domain) blocker | |||
| 0.077 | 0.027 | 0.077 | Glutamate (mGluR6) antagonist | 0.062 0.06 CHEMBL71733 0.073 0.033 CHEMBL3542327 | ||
| 0.078 | 0.028 | 0.078 | Aryl hydrocarbon receptor antagonist | |||
| 0.07 | 0.021 | 0.07 | MAP kinase kinase 9 inhibitor | 0.053 0.045 CHEMBL3542314 | ||
| 0.072 | 0.023 | 0.072 | Botulinum neurotoxin type A inhibitor | |||
| 0.125 | 0.076 | 0.126 | NADPH oxidase inhibitor | 0.126 0.076 CHEMBL3542314 | CHEMBL3542314 | |
| 0.109 | 0.06 | 0.109 | AMP-activated protein kinase stimulant | 0.096 0.076 CHEMBL3542314 | ||
| 0.135 | 0.086 | 0.135 | Pregnane X receptor agonist | 0.132 0.095 CHEMBL71733 0.125 0.115 CHEMBL3542326 | ||
| 0.061 | 0.012 | 0.061 | Glutamate (mGluR group II) agonist | 0.049 0.016 CHEMBL71733 | ||
| 0.107 | 0.059 | 0.107 | Carbonic anhydrase XV inhibitor | |||
| 0.115 | 0.067 | 0.115 | Interleukin 1b antagonist | |||
| 0.138 | 0.091 | 0.161 | Anticoagulant | 0.152 0.079 CHEMBL71733 0.161 0.072 CHEMBL3542327 0.139 0.09 CHEMBL3542314 | CHEMBL3542327 | |
| 0.076 | 0.03 | 0.127 | DNA gyrase inhibitor | 0.061 0.047 CHEMBL3542327 0.127 0.011 CHEMBL3542314 | CHEMBL3542314 | |
| 0.052 | 0.007 | 0.052 | Protein kinase (CK2) beta inhibitor | 0.031 0.03 CHEMBL71733 0.031 0.03 CHEMBL3542314 | ||
| 0.07 | 0.025 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.075 | 0.031 | 0.075 | 5 Hydroxytryptamine 3 agonist | 0.074 0.032 CHEMBL71733 0.057 0.054 CHEMBL3542314 0.062 0.045 CHEMBL3542326 | ||
| 0.073 | 0.029 | 0.073 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.144 | 0.099 | 0.144 | Interleukin 6 antagonist | |||
| 0.086 | 0.042 | 0.086 | Protein kinase B gamma inhibitor | |||
| 0.056 | 0.012 | 0.056 | Glutamate (mGluR2) agonist | 0.045 0.015 CHEMBL71733 | ||
| 0.07 | 0.026 | 0.09 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.04 CHEMBL71733 0.09 0.019 CHEMBL3542314 | CHEMBL3542314 | |
| 0.07 | 0.026 | 0.194 | Bruton tyrosine kinase inhibitor | 0.194 0.005 CHEMBL3542314 | CHEMBL3542314 | |
| 0.091 | 0.048 | 0.091 | MAP-kinase-activated kinase inhibitor | |||
| 0.164 | 0.121 | 0.164 | Potassium channel blocker | |||
| 0.055 | 0.013 | 0.055 | Glutamate (mGluR group II) antagonist | 0.036 0.029 CHEMBL71733 | ||
| 0.068 | 0.025 | 0.075 | Cyclin A1 inhibitor | 0.062 0.034 CHEMBL71733 0.074 0.018 CHEMBL3542327 0.075 0.017 CHEMBL3542314 | CHEMBL3542314 | |
| 0.047 | 0.005 | 0.049 | CXC chemokine receptor agonist | 0.037 0.02 CHEMBL71733 0.049 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.049 | 0.007 | 0.049 | Transforming growth factor beta 2 antagonist | |||
| 0.109 | 0.067 | 0.109 | GABA receptor agonist | |||
| 0.052 | 0.011 | 0.052 | MAP3K5 inhibitor | 0.041 0.023 CHEMBL71733 0.04 0.026 CHEMBL3542326 | ||
| 0.046 | 0.005 | 0.046 | Nicotinic alpha4beta2 receptor agonist | 0.029 0.019 CHEMBL71733 0.038 0.009 CHEMBL3542327 0.027 0.022 CHEMBL3542314 | ||
| 0.071 | 0.03 | 0.071 | Argininosuccinate synthase inhibitor | 0.058 0.039 CHEMBL3542327 | ||
| 0.109 | 0.069 | 0.109 | Glycogen synthase kinase-3 beta inhibitor | 0.103 0.074 CHEMBL3542314 | ||
| 0.067 | 0.026 | 0.067 | Protein kinase C theta inhibitor | |||
| 0.049 | 0.009 | 0.049 | ATM kinase inhibitor | 0.038 0.021 CHEMBL71733 0.041 0.016 CHEMBL3542314 | ||
| 0.067 | 0.028 | 0.09 | Fatty acid synthase inhibitor | 0.09 0.014 CHEMBL3542327 | CHEMBL3542327 | |
| 0.061 | 0.022 | 0.061 | Immunoglobulin Fc receptor antagonist | |||
| 0.172 | 0.133 | 0.653 | Tumour necrosis factor alpha release inhibitor | 0.653 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.049 | 0.011 | 0.049 | Glutamate (mGluR4) agonist | |||
| 0.123 | 0.084 | 0.123 | Interleukin 1 antagonist | |||
| 0.088 | 0.05 | 0.088 | Glutathione S-transferase inhibitor | 0.078 0.064 CHEMBL71733 | ||
| 0.042 | 0.004 | 0.042 | Glucosylceramidase stimulant | |||
| 0.045 | 0.007 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.026 CHEMBL71733 | ||
| 0.117 | 0.079 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.082 CHEMBL3542327 | ||
| 0.139 | 0.101 | 0.139 | Arachidonic acid antagonist | |||
| 0.059 | 0.021 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 CHEMBL71733 0.059 0.022 CHEMBL3542314 0.043 0.038 CHEMBL3542326 | CHEMBL71733 | |
| 0.097 | 0.06 | 0.139 | CDK2/cyclin A inhibitor | 0.089 0.068 CHEMBL3542327 0.139 0.031 CHEMBL3542314 | CHEMBL3542314 | |
| 0.041 | 0.004 | 0.041 | ICAM 1 antagonist | |||
| 0.08 | 0.044 | 0.099 | Polo-like kinase-2 inhibitor | 0.099 0.026 CHEMBL71733 0.091 0.034 CHEMBL3542314 0.075 0.048 CHEMBL3542326 | CHEMBL71733 | |
| 0.069 | 0.032 | 0.069 | Carbonic anhydrase stimulant | |||
| 0.114 | 0.078 | 0.114 | Cyclin-dependent kinase inhibitor | |||
| 0.042 | 0.006 | 0.052 | MAP3K8 inhibitor | 0.052 0.004 CHEMBL3542327 0.027 0.026 CHEMBL3542314 | CHEMBL3542327 | |
| 0.051 | 0.015 | 0.051 | TRPM8 blocker | |||
| 0.108 | 0.072 | 0.108 | Glycogen synthase kinase-3 inhibitor | 0.097 0.082 CHEMBL3542314 | ||
| 0.082 | 0.046 | 0.082 | MAP kinase 11 inhibitor | 0.068 0.057 CHEMBL3542327 | ||
| 0.068 | 0.032 | 0.086 | Glutamate (mGluR1) antagonist | 0.086 0.02 CHEMBL3542327 | CHEMBL3542327 | |
| 0.064 | 0.028 | 0.072 | Toll-Like receptor 8 antagonist | 0.072 0.022 CHEMBL3542314 | CHEMBL3542314 | |
| 0.157 | 0.121 | 0.277 | Anticonvulsant | 0.207 0.077 CHEMBL71733 0.277 0.047 CHEMBL3542327 0.176 0.102 CHEMBL3542314 | CHEMBL3542327 | |
| 0.065 | 0.03 | 0.065 | Phosphodiesterase 1A inhibitor | 0.058 0.046 CHEMBL71733 0.059 0.043 CHEMBL3542314 | ||
| 0.055 | 0.02 | 0.055 | Stearoyl-CoA desaturase inhibitor | |||
| 0.041 | 0.006 | 0.041 | Purinergic P2Y15 antagonist | 0.031 0.015 CHEMBL71733 0.03 0.018 CHEMBL3542327 | ||
| 0.149 | 0.115 | 0.149 | Anesthetic general | |||
| 0.07 | 0.036 | 0.07 | CXC chemokine 4 receptor antagonist | 0.055 0.046 CHEMBL3542327 | ||
| 0.049 | 0.016 | 0.049 | Factor XIIIa inhibitor | 0.049 0.016 CHEMBL3542327 | ||
| 0.066 | 0.034 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CHEMBL71733 0.066 0.035 CHEMBL3542314 | ||
| 0.065 | 0.033 | 0.065 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.059 0.046 CHEMBL71733 0.058 0.047 CHEMBL3542314 0.061 0.041 CHEMBL3542326 | ||
| 0.067 | 0.035 | 0.067 | Transcription factor RelA inhibitor | 0.059 0.058 CHEMBL3542327 | ||
| 0.048 | 0.017 | 0.048 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 CHEMBL3542314 | ||
| 0.096 | 0.064 | 0.096 | Sphingomyelinase inhibitor | |||
| 0.076 | 0.044 | 0.085 | Syk tyrosine kinase inhibitor | 0.085 0.037 CHEMBL71733 0.07 0.05 CHEMBL3542314 0.065 0.054 CHEMBL3542326 | CHEMBL71733 | |
| 0.049 | 0.017 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.042 0.024 CHEMBL71733 | ||
| 0.042 | 0.011 | 0.042 | Glutamate (mGluR2) antagonist | 0.027 0.025 CHEMBL71733 | ||
| 0.074 | 0.043 | 0.074 | Glutamate (mGluR group I) antagonist | |||
| 0.13 | 0.099 | 0.13 | Src kinase inhibitor | |||
| 0.042 | 0.012 | 0.042 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.089 | 0.059 | 0.089 | Phosphodiesterase I inhibitor | 0.087 0.063 CHEMBL3542314 | ||
| 0.098 | 0.069 | 0.098 | Hedgehog signaling inhibitor | |||
| 0.113 | 0.084 | 0.113 | RET inhibitor | |||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.026 0.025 CHEMBL71733 | ||
| 0.084 | 0.057 | 0.084 | GABA A receptor agonist | |||
| 0.062 | 0.035 | 0.062 | Potassium channel Kv1.5 blocker | |||
| 0.142 | 0.116 | 0.142 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.031 | 0.004 | 0.031 | Nicotinic alpha4 receptor agonist | 0.021 0.007 CHEMBL3542327 | ||
| 0.104 | 0.078 | 0.104 | Aurora-B kinase inhibitor | |||
| 0.052 | 0.027 | 0.052 | Aldosterone antagonist | 0.045 0.038 CHEMBL71733 | ||
| 0.082 | 0.056 | 0.094 | Caspase 7 inhibitor | 0.094 0.035 CHEMBL71733 | CHEMBL71733 | |
| 0.043 | 0.018 | 0.045 | VCAM-1 antagonist | 0.045 0.014 CHEMBL3542327 | CHEMBL3542327 | |
| 0.03 | 0.005 | 0.03 | Cyclin T1 inhibitor | 0.025 0.007 CHEMBL3542327 | ||
| 0.029 | 0.004 | 0.029 | Complement factor D inhibitor | 0.022 0.006 CHEMBL71733 0.024 0.005 CHEMBL3542327 0.018 0.013 CHEMBL3542314 | ||
| 0.043 | 0.018 | 0.043 | Potassium channel Kv1.1 blocker | |||
| 0.19 | 0.165 | 0.194 | Gastrin inhibitor | 0.194 0.158 CHEMBL3542314 | CHEMBL3542314 | |
| 0.043 | 0.018 | 0.045 | VCAM antagonist | 0.045 0.015 CHEMBL3542327 | CHEMBL3542327 | |
| 0.046 | 0.021 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 CHEMBL3542327 | CHEMBL3542327 | |
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR8) agonist | 0.039 0.023 CHEMBL3542327 | ||
| 0.076 | 0.051 | 0.076 | GABA B receptor agonist | |||
| 0.032 | 0.008 | 0.032 | Glutamate (mGluR1a) agonist | 0.02 0.019 CHEMBL3542327 | ||
| 0.151 | 0.127 | 0.411 | Platelet aggregation inhibitor | 0.411 0.017 CHEMBL3542327 | CHEMBL3542327 | |
| 0.088 | 0.064 | 0.14 | Potassium channel activator | 0.14 0.024 CHEMBL3542327 | CHEMBL3542327 | |
| 0.152 | 0.129 | 0.298 | HERG channel blocker | 0.252 0.065 CHEMBL71733 0.298 0.049 CHEMBL3542314 | CHEMBL3542314 | |
| 0.083 | 0.06 | 0.083 | Myeloperoxidase inhibitor | |||
| 0.046 | 0.023 | 0.046 | Glutamate (mGluR1a) antagonist | |||
| 0.042 | 0.019 | 0.042 | Delayed rectifier potassium channel blocker | 0.034 0.033 CHEMBL71733 0.034 0.032 CHEMBL3542314 | ||
| 0.039 | 0.016 | 0.039 | Calcium release-activated channel blocker | |||
| 0.092 | 0.069 | 0.092 | Phosphodiesterase 6D inhibitor | |||
| 0.084 | 0.061 | 0.091 | Acetylcholine agonist | 0.091 0.054 CHEMBL71733 0.081 0.065 CHEMBL3542314 | CHEMBL71733 | |
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | 0.043 0.025 CHEMBL71733 0.041 0.028 CHEMBL3542327 0.039 0.035 CHEMBL3542314 | ||
| 0.093 | 0.071 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.062 CHEMBL3542327 | CHEMBL3542327 | |
| 0.083 | 0.061 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.08 | 0.059 | 0.08 | Phosphodiesterase 11A inhibitor | |||
| 0.08 | 0.059 | 0.08 | Phosphodiesterase XI inhibitor | |||
| 0.035 | 0.014 | 0.044 | Uridine phosphorylase inhibitor | 0.044 0.01 CHEMBL3542314 | CHEMBL3542314 | |
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR3) antagonist | |||
| 0.098 | 0.077 | 0.098 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.024 | 0.004 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 CHEMBL71733 0.015 0.007 CHEMBL3542327 0.013 0.01 CHEMBL3542314 | ||
| 0.094 | 0.074 | 0.094 | Urease inhibitor | |||
| 0.056 | 0.036 | 0.063 | Ribonucleoside-diphosphate reductase inhibitor | 0.063 0.032 CHEMBL3542327 | CHEMBL3542327 | |
| 0.073 | 0.053 | 0.073 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.036 | 0.016 | 0.043 | 5 Hydroxytryptamine 1D agonist | 0.043 0.013 CHEMBL71733 0.034 0.017 CHEMBL3542314 | CHEMBL71733 | |
| 0.099 | 0.08 | 0.099 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.151 | 0.132 | 0.151 | Insulin sensitizer | |||
| 0.04 | 0.021 | 0.04 | Vanilloid 3 antagonist | |||
| 0.049 | 0.03 | 0.049 | Glutamate (mGluR5) antagonist | |||
| 0.057 | 0.038 | 0.057 | Kallikrein 1 inhibitor | 0.052 0.049 CHEMBL3542314 | ||
| 0.038 | 0.02 | 0.054 | Plasma kallikrein inhibitor | 0.053 0.011 CHEMBL3542327 0.054 0.01 CHEMBL3542314 | CHEMBL3542314 | |
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) blocker | |||
| 0.05 | 0.033 | 0.05 | Bombesin 2 receptor antagonist | |||
| 0.049 | 0.032 | 0.049 | Cytokine production stimulant | |||
| 0.056 | 0.039 | 0.064 | Ribonucleotide reductase inhibitor | 0.064 0.034 CHEMBL3542327 | CHEMBL3542327 | |
| 0.077 | 0.06 | 0.077 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.037 | 0.02 | 0.037 | Sirtuin 2 inhibitor | 0.03 0.026 CHEMBL71733 | ||
| 0.08 | 0.064 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.087 0.052 CHEMBL3542314 | CHEMBL3542314 | |
| 0.05 | 0.033 | 0.05 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.056 | 0.039 | 0.06 | 5 Hydroxytryptamine 7 agonist | 0.06 0.031 CHEMBL71733 0.052 0.048 CHEMBL3542314 | CHEMBL71733 | |
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.029 CHEMBL3542327 | ||
| 0.03 | 0.015 | 0.03 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.077 | 0.061 | 0.077 | Adrenaline agonist | |||
| 0.021 | 0.005 | 0.021 | CDK2/cyclin A3 inhibitor | |||
| 0.059 | 0.043 | 0.059 | Phosphodiesterase 1B inhibitor | |||
| 0.044 | 0.028 | 0.044 | Oxytocin agonist | 0.038 0.034 CHEMBL71733 0.037 0.036 CHEMBL3542314 | ||
| 0.048 | 0.033 | 0.056 | Antimetabolite | 0.056 0.028 CHEMBL3542327 | CHEMBL3542327 | |
| 0.055 | 0.04 | 0.055 | Beta 1 adrenoreceptor antagonist | |||
| 0.019 | 0.004 | 0.019 | Antibiotic Tetracycline-like | 0.019 0.005 CHEMBL71733 0.018 0.005 CHEMBL3542327 0.018 0.005 CHEMBL3542314 0.019 0.004 CHEMBL3542326 | ||
| 0.056 | 0.041 | 0.056 | Xanthine dehydrogenase inhibitor | |||
| 0.052 | 0.038 | 0.052 | Ornithine carbamoyltransferase inhibitor | |||
| 0.027 | 0.013 | 0.035 | Complement factor 1s inhibitor | 0.035 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.044 | 0.031 | 0.044 | AICAR transformylase inhibitor | |||
| 0.052 | 0.04 | 0.068 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CHEMBL71733 0.068 0.019 CHEMBL3542314 | CHEMBL3542314 | |
| 0.064 | 0.052 | 0.064 | Sirtuin 1 inhibitor | 0.063 0.054 CHEMBL71733 | ||
| 0.034 | 0.021 | 0.034 | ATR kinase inhibitor | |||
| 0.014 | 0.002 | 0.014 | CC chemokine 6 receptor agonist | 0.006 0.005 CHEMBL3542327 | ||
| 0.028 | 0.016 | 0.028 | CXC chemokine 2 receptor antagonist | 0.028 0.015 CHEMBL3542327 | ||
| 0.05 | 0.037 | 0.051 | H+/K+-transporting ATPase inhibitor | 0.051 0.035 CHEMBL3542327 | CHEMBL3542327 | |
| 0.03 | 0.018 | 0.03 | CDK4/cyclin D3 inhibitor | |||
| 0.055 | 0.044 | 0.062 | Pregnane X receptor antagonist | 0.062 0.026 CHEMBL3542327 | CHEMBL3542327 | |
| 0.068 | 0.057 | 0.116 | Catalase inhibitor | 0.101 0.038 CHEMBL71733 0.116 0.034 CHEMBL3542314 | CHEMBL3542314 | |
| 0.019 | 0.009 | 0.026 | CC chemokine 9 receptor antagonist | 0.026 0.004 CHEMBL3542327 | CHEMBL3542327 | |
| 0.023 | 0.014 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.025 0.011 CHEMBL71733 0.026 0.009 CHEMBL3542314 0.022 0.017 CHEMBL3542326 | CHEMBL3542314 | |
| 0.017 | 0.008 | 0.017 | CXC chemokine 4 receptor agonist | |||
| 0.051 | 0.042 | 0.051 | Human rhinovirus A protease inhibitor | |||
| 0.021 | 0.013 | 0.021 | Factor XIII inhibitor | |||
| 0.04 | 0.031 | 0.04 | Plasmepsin II inhibitor | |||
| 0.062 | 0.053 | 0.09 | 5 Hydroxytryptamine 3A antagonist | 0.086 0.025 CHEMBL71733 0.09 0.022 CHEMBL3542314 | CHEMBL3542314 | |
| 0.078 | 0.07 | 0.109 | Histamine H2 receptor antagonist | 0.109 0.027 CHEMBL3542327 | CHEMBL3542327 | |
| 0.098 | 0.09 | 0.098 | Proteasome inhibitor | |||
| 0.044 | 0.036 | 0.063 | Kallikrein inhibitor | 0.059 0.024 CHEMBL3542327 0.063 0.022 CHEMBL3542314 | CHEMBL3542314 | |
| 0.033 | 0.025 | 0.038 | Fumarate hydratase inhibitor | 0.038 0.021 CHEMBL3542314 | CHEMBL3542314 | |
| 0.102 | 0.095 | 0.102 | Nav1.3 sodium channel blocker | |||
| 0.078 | 0.07 | 0.078 | Ornithine decarboxylase inhibitor | |||
| 0.028 | 0.021 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 CHEMBL71733 | ||
| 0.043 | 0.037 | 0.043 | Thymidylate synthase inhibitor | |||
| 0.028 | 0.021 | 0.049 | Cyclin E2 inhibitor | 0.038 0.013 CHEMBL71733 0.026 0.022 CHEMBL3542314 0.049 0.009 CHEMBL3542326 | CHEMBL3542326 | |
| 0.121 | 0.115 | 0.129 | Phospholipase A2 inhibitor | 0.123 0.112 CHEMBL71733 0.129 0.102 CHEMBL3542327 | CHEMBL3542327 | |
| 0.022 | 0.016 | 0.028 | Follicle-stimulating hormone agonist | 0.028 0.011 CHEMBL3542327 | CHEMBL3542327 | |
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.217 | 0.211 | 0.217 | Transcription factor inhibitor | |||
| 0.045 | 0.039 | 0.591 | Phosphodiesterase 4A inhibitor | 0.591 0.003 CHEMBL3542327 | CHEMBL3542327 | |
| 0.074 | 0.068 | 0.076 | MAP kinase 7 inhibitor | 0.076 0.058 CHEMBL3542314 | CHEMBL3542314 | |
| 0.086 | 0.081 | 0.139 | Carbonic anhydrase III inhibitor | 0.139 0.033 CHEMBL3542327 | CHEMBL3542327 | |
| 0.029 | 0.024 | 0.029 | Epoxide hydrolase 1 inhibitor | |||
| 0.012 | 0.007 | 0.012 | Thrombopoietin agonist | |||
| 0.075 | 0.071 | 0.091 | Inducible nitric-oxide synthase inhibitor | 0.091 0.046 CHEMBL3542327 | CHEMBL3542327 | |
| 0.019 | 0.015 | 0.019 | Hexokinase stimulant | |||
| 0.078 | 0.074 | 0.078 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.006 | 0.002 | 0.006 | Reverse transcriptase (HBV) inhibitor | |||
| 0.062 | 0.058 | 0.062 | Protein kinase C alpha inhibitor | |||
| 0.019 | 0.015 | 0.024 | Follicle-stimulating hormone antagonist | 0.024 0.006 CHEMBL3542327 | CHEMBL3542327 | |
| 0.148 | 0.145 | 0.148 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.039 | 0.036 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.023 | 0.02 | 0.023 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.026 | 0.023 | 0.026 | Thrombin receptor antagonist | |||
| 0.041 | 0.039 | 0.052 | Dipeptidyl peptidase IV inhibitor | 0.052 0.018 CHEMBL3542314 | CHEMBL3542314 | |
| 0.036 | 0.033 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.078 | 0.075 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.056 CHEMBL71733 0.082 0.059 CHEMBL3542314 | CHEMBL71733 | |
| 0.019 | 0.017 | 0.019 | Toll-Like receptor 8 agonist | |||
| 0.062 | 0.06 | 0.062 | CDK2/cyclin E2 inhibitor | |||
| 0.048 | 0.046 | 0.064 | Dipeptidyl peptidase inhibitor | 0.064 0.022 CHEMBL3542314 | CHEMBL3542314 | |
| 0.045 | 0.044 | 0.045 | Beta 2 adrenoreceptor antagonist | |||
| 0.016 | 0.015 | 0.016 | Nicotinic acid receptor 1 antagonist | |||
| 0.045 | 0.044 | 0.045 | Prolyl endopeptidase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Egl nine homolog 3 inhibitor | |||
| 0.089 | 0.089 | 0.317 | Platelet activating factor antagonist | 0.317 0.01 CHEMBL3542327 0.107 0.073 CHEMBL3542326 | CHEMBL3542327 | |
| 0.026 | 0.028 | 0.034 | Purinergic P2Y14 antagonist | 0.034 0.017 CHEMBL3542327 | CHEMBL3542327 | |
| 0.136 | 0.138 | 0.141 | Non-steroidal antiinflammatory agent | 0.141 0.128 CHEMBL3542327 | CHEMBL3542327 | |
| 0.041 | 0.043 | 0.095 | AMPA receptor antagonist | 0.095 0.013 CHEMBL3542327 | CHEMBL3542327 | |
| 0.031 | 0.033 | 0.033 | Histone deacetylase 7 inhibitor | 0.033 0.03 CHEMBL71733 | CHEMBL71733 | |
| 0.11 | 0.113 | 0.18 | Neurotrophic factor | 0.18 0.038 CHEMBL3542327 | CHEMBL3542327 | |
| 0.034 | 0.039 | 0.043 | Histone deacetylase 9 inhibitor | 0.043 0.021 CHEMBL3542327 | CHEMBL3542327 | |
| 0.028 | 0.033 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.026 CHEMBL3542314 | CHEMBL3542314 | |
| 0.069 | 0.077 | 0.08 | Opioid kappa receptor antagonist | 0.08 0.057 CHEMBL71733 | CHEMBL71733 | |
| 0.035 | 0.042 | 0.063 | Factor Xa inhibitor | 0.047 0.031 CHEMBL71733 0.063 0.023 CHEMBL3542327 | CHEMBL3542327 | |
| 0.037 | 0.045 | 0.042 | GABA B receptor antagonist | 0.04 0.034 CHEMBL71733 0.042 0.032 CHEMBL3542326 | CHEMBL3542326 | |
| 0.047 | 0.055 | 0.079 | Cannabinoid CB1 receptor agonist | 0.079 0.029 CHEMBL3542327 | CHEMBL3542327 | |
| 0.077 | 0.086 | 0.117 | Prolactin inhibitor | 0.117 0.04 CHEMBL71733 0.113 0.043 CHEMBL3542314 0.093 0.063 CHEMBL3542326 | CHEMBL71733 | |
| 0.209 | 0.219 | 0.416 | Antibacterial | 0.315 0.124 CHEMBL71733 0.301 0.135 CHEMBL3542327 0.249 0.177 CHEMBL3542314 0.416 0.07 CHEMBL3542326 | CHEMBL3542326 | |
| 0.129 | 0.14 | 0.206 | DNA methylase inhibitor | 0.154 0.114 CHEMBL71733 0.206 0.075 CHEMBL3542314 0.174 0.097 CHEMBL3542326 | CHEMBL3542314 | |
| 0.043 | 0.055 | 0.067 | Plasminogen activator inhibitor | 0.067 0.034 CHEMBL3542327 | CHEMBL3542327 | |
| 0.036 | 0.049 | 0.049 | Cathepsin F inhibitor | 0.049 0.014 CHEMBL3542327 | CHEMBL3542327 | |
| 0.049 | 0.062 | 0.089 | 5 Hydroxytryptamine 1D antagonist | 0.089 0.027 CHEMBL71733 0.08 0.031 CHEMBL3542314 | CHEMBL71733 | |
| 0.048 | 0.064 | 0.069 | Adenosine A2 receptor antagonist | 0.069 0.041 CHEMBL3542314 | CHEMBL3542314 | |
| 0.015 | 0.031 | 0.031 | Geranylgeranyltransferase inhibitor | 0.022 0.015 CHEMBL71733 0.031 0.009 CHEMBL3542314 | CHEMBL3542314 | |
| 0.074 | 0.091 | 0.09 | CC chemokine 5 receptor agonist | 0.09 0.037 CHEMBL3542327 | CHEMBL3542327 | |
| 0.03 | 0.047 | 0.034 | Adenosine uptake inhibitor | 0.034 0.027 CHEMBL71733 0.034 0.027 CHEMBL3542314 | CHEMBL3542314 | |
| 0.081 | 0.099 | 0.11 | Alpha 2b adrenoreceptor antagonist | 0.11 0.067 CHEMBL71733 | CHEMBL71733 | |
| 0.022 | 0.042 | 0.046 | Kainate receptor 2 antagonist | 0.046 0.018 CHEMBL3542327 | CHEMBL3542327 | |
| 0.051 | 0.072 | 0.064 | Ryanodine receptor antagonist | 0.064 0.029 CHEMBL71733 0.056 0.053 CHEMBL3542326 | CHEMBL71733 | |
| 0.057 | 0.079 | 0.075 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.056 CHEMBL3542314 | CHEMBL3542314 | |
| 0.05 | 0.071 | 0.06 | 5 Hydroxytryptamine 5A antagonist | 0.06 0.045 CHEMBL3542314 | CHEMBL3542314 | |
| 0.052 | 0.074 | 0.096 | MAP kinase 14 inhibitor | 0.096 0.038 CHEMBL3542327 | CHEMBL3542327 | |
| 0.072 | 0.095 | 0.348 | Bronchodilator | 0.348 0.007 CHEMBL3542327 | CHEMBL3542327 | |
| 0.046 | 0.069 | 0.053 | 5 Hydroxytryptamine 5 antagonist | 0.053 0.05 CHEMBL3542314 | CHEMBL3542314 | |
| 0.085 | 0.11 | 0.162 | Alkylator | 0.151 0.046 CHEMBL71733 0.098 0.09 CHEMBL3542327 0.106 0.082 CHEMBL3542314 0.162 0.041 CHEMBL3542326 | CHEMBL3542326 | |
| 0.051 | 0.078 | 0.076 | Carbonic anhydrase VA inhibitor | 0.076 0.04 CHEMBL3542327 | CHEMBL3542327 | |
| 0.18 | 0.209 | 0.308 | Calpain 2 inhibitor | 0.308 0.109 CHEMBL3542327 | CHEMBL3542327 | |
| 0.102 | 0.132 | 0.12 | Thrombolytic | 0.12 0.111 CHEMBL71733 | CHEMBL71733 | |
| 0.171 | 0.201 | 0.31 | Immunomodulator | 0.203 0.16 CHEMBL71733 0.31 0.077 CHEMBL3542314 0.287 0.09 CHEMBL3542326 | CHEMBL3542314 | |
| 0.057 | 0.087 | 0.123 | Histamine H1 receptor antagonist | 0.123 0.031 CHEMBL3542327 | CHEMBL3542327 | |
| 0.064 | 0.096 | 0.159 | Potassium channel (Ca-activated) activator | 0.159 0.025 CHEMBL3542327 | CHEMBL3542327 | |
| 0.032 | 0.066 | 0.066 | Carbonic anhydrase VB inhibitor | 0.066 0.03 CHEMBL3542327 | CHEMBL3542327 | |
| 0.067 | 0.101 | 0.076 | Factor XII inhibitor | 0.076 0.074 CHEMBL3542327 | CHEMBL3542327 | |
| 0.012 | 0.048 | 0.023 | CXC chemokine 5 receptor antagonist | 0.023 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.014 | 0.051 | 0.026 | AMPA 3 receptor antagonist | 0.026 0.023 CHEMBL3542327 | CHEMBL3542327 | |
| 0.039 | 0.077 | 0.062 | Cannabinoid receptor agonist | 0.062 0.047 CHEMBL3542327 | CHEMBL3542327 | |
| 0.07 | 0.108 | 0.111 | DNA directed RNA polymerase inhibitor | 0.111 0.045 CHEMBL3542327 | CHEMBL3542327 | |
| 0.038 | 0.079 | 0.063 | Adenosine A2a receptor antagonist | 0.063 0.042 CHEMBL3542314 | CHEMBL3542314 | |
| 0.042 | 0.085 | 0.07 | Carbonic anhydrase V inhibitor | 0.07 0.043 CHEMBL3542327 | CHEMBL3542327 | |
| 0.038 | 0.082 | 0.081 | 5 Hydroxytryptamine 2A agonist | 0.081 0.027 CHEMBL3542314 | CHEMBL3542314 | |
| 0.025 | 0.068 | 0.059 | Factor XIa inhibitor | 0.04 0.03 CHEMBL3542327 0.059 0.013 CHEMBL3542314 | CHEMBL3542314 | |
| 0.017 | 0.061 | 0.026 | Acid ceramidase inhibitor | 0.026 0.018 CHEMBL71733 0.025 0.019 CHEMBL3542314 | CHEMBL71733 | |
| 0.082 | 0.127 | 0.1 | Microtubule formation inhibitor | 0.1 0.091 CHEMBL3542314 | CHEMBL3542314 | |
| 0.037 | 0.082 | 0.131 | p38 MAP kinase inhibitor | 0.131 0.023 CHEMBL3542327 | CHEMBL3542327 | |
| 0.08 | 0.128 | 0.106 | Cholinergic antagonist | 0.106 0.087 CHEMBL71733 | CHEMBL71733 | |
| 0.079 | 0.128 | 0.101 | Acetylcholine antagonist | 0.101 0.092 CHEMBL71733 | CHEMBL71733 | |
| 0.057 | 0.106 | 0.089 | Carbonic anhydrase VI inhibitor | 0.089 0.048 CHEMBL3542327 | CHEMBL3542327 | |
| 0.056 | 0.106 | 0.202 | AXL receptor tyrosine kinase inhibitor | 0.202 0.009 CHEMBL3542326 | CHEMBL3542326 | |
| 0.063 | 0.115 | 0.104 | Antihistaminic | 0.104 0.052 CHEMBL3542327 | CHEMBL3542327 | |
| 0.026 | 0.079 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.03 CHEMBL3542327 | CHEMBL3542327 | |
| 0.013 | 0.067 | 0.048 | Factor X inhibitor | 0.048 0.022 CHEMBL3542327 | CHEMBL3542327 | |
| 0.058 | 0.113 | 0.105 | Monophenol monooxygenase inhibitor | 0.105 0.072 CHEMBL3542327 | CHEMBL3542327 | |
| 0.009 | 0.065 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.006 CHEMBL3542327 | CHEMBL3542327 | |
| 0.017 | 0.074 | 0.041 | Kainate receptor antagonist | 0.041 0.028 CHEMBL3542327 | CHEMBL3542327 | |
| 0.06 | 0.119 | 0.165 | Hepatocyte growth factor antagonist | 0.165 0.018 CHEMBL3542326 | CHEMBL3542326 | |
| 0.052 | 0.114 | 0.095 | Histamine antagonist | 0.095 0.051 CHEMBL3542327 | CHEMBL3542327 | |
| 0.028 | 0.096 | 0.048 | 5 Hydroxytryptamine 2 agonist | 0.045 0.044 CHEMBL71733 0.048 0.04 CHEMBL3542314 | CHEMBL3542314 | |
| 0.041 | 0.109 | 0.072 | Carbonic anhydrase XIII inhibitor | 0.072 0.056 CHEMBL3542327 | CHEMBL3542327 | |
| 0.03 | 0.099 | 0.062 | 5 Hydroxytryptamine 3 antagonist | 0.06 0.035 CHEMBL71733 0.062 0.034 CHEMBL3542314 | CHEMBL3542314 | |
| 0.084 | 0.153 | 0.143 | Toll-Like receptor antagonist | 0.109 0.105 CHEMBL71733 0.143 0.061 CHEMBL3542314 | CHEMBL3542314 | |
| 0.044 | 0.117 | 0.066 | Thrombin inhibitor | 0.066 0.06 CHEMBL3542327 | CHEMBL3542327 | |
| 0.085 | 0.16 | 0.114 | Protein kinase stimulant | 0.114 0.099 CHEMBL71733 | CHEMBL71733 | |
| 0.048 | 0.123 | 0.078 | Androgen antagonist | 0.078 0.068 CHEMBL3542314 | CHEMBL3542314 | |
| 0.062 | 0.142 | 0.092 | Thioredoxin reductase inhibitor | 0.092 0.038 CHEMBL3542326 | CHEMBL3542326 | |
| 0.047 | 0.132 | 0.1 | MAO A inhibitor | 0.1 0.064 CHEMBL71733 | CHEMBL71733 | |
| 0.032 | 0.117 | 0.061 | 5 Hydroxytryptamine 1B agonist | 0.061 0.026 CHEMBL3542314 | CHEMBL3542314 | |
| 0.085 | 0.173 | 0.129 | Acetylcholine M1 receptor antagonist | 0.129 0.097 CHEMBL71733 0.12 0.109 CHEMBL3542314 | CHEMBL71733 | |
| 0.12 | 0.209 | 0.419 | Vasodilator | 0.419 0.02 CHEMBL3542327 | CHEMBL3542327 | |
| 0.006 | 0.099 | 0.035 | Growth hormone releasing factor antagonist | 0.035 0.011 CHEMBL3542327 | CHEMBL3542327 | |
| 0.058 | 0.151 | 0.117 | MAO inhibitor | 0.115 0.077 CHEMBL71733 0.117 0.076 CHEMBL3542326 | CHEMBL3542326 | |
| 0.027 | 0.126 | 0.148 | Farnesyltransferase inhibitor | 0.148 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.025 | 0.124 | 0.052 | 5 Hydroxytryptamine 4 antagonist | 0.052 0.035 CHEMBL71733 | CHEMBL71733 | |
| 0.015 | 0.116 | 0.038 | Factor XI inhibitor | 0.038 0.018 CHEMBL3542327 0.035 0.022 CHEMBL3542314 | CHEMBL3542327 | |
| 0.016 | 0.118 | 0.043 | CDK6/cyclin D3 inhibitor | 0.043 0.011 CHEMBL3542314 | CHEMBL3542314 | |
| 0.16 | 0.263 | 0.221 | DNA directed DNA polymerase inhibitor | 0.221 0.212 CHEMBL3542314 | CHEMBL3542314 | |
| 0.016 | 0.126 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.044 0.036 CHEMBL3542314 | CHEMBL3542314 | |
| 0.01 | 0.125 | 0.034 | Histone deacetylase 4 inhibitor | 0.034 0.021 CHEMBL3542327 | CHEMBL3542327 | |
| 0.046 | 0.163 | 0.318 | Chemokine receptor antagonist | 0.318 0.006 CHEMBL3542327 | CHEMBL3542327 | |
| 0.014 | 0.131 | 0.026 | CC chemokine 8 receptor antagonist | 0.026 0.01 CHEMBL3542327 | CHEMBL3542327 | |
| 0.065 | 0.184 | 0.57 | Phosphodiesterase inhibitor | 0.57 0.005 CHEMBL3542327 | CHEMBL3542327 | |
| 0.009 | 0.135 | 0.015 | CC chemokine 10 receptor antagonist | 0.015 0.012 CHEMBL3542327 | CHEMBL3542327 | |
| 0.085 | 0.215 | 0.138 | DNA methyltransferase I inhibitor | 0.138 0.119 CHEMBL3542314 | CHEMBL3542314 | |
| 0.013 | 0.146 | 0.038 | Cyclin D3 inhibitor | 0.038 0.028 CHEMBL3542314 | CHEMBL3542314 | |
| 0.026 | 0.162 | 0.078 | Phosphodiesterase 7A inhibitor | 0.059 0.024 CHEMBL3542314 0.078 0.007 CHEMBL3542326 | CHEMBL3542326 | |
| 0.004 | 0.142 | 0.017 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 CHEMBL3542314 | CHEMBL3542314 | |
| 0.031 | 0.171 | 0.061 | Cyclin B3 inhibitor | 0.061 0.054 CHEMBL3542314 | CHEMBL3542314 | |
| 0.023 | 0.169 | 0.353 | Bromodomain-containing protein 4 inhibitor | 0.05 0.046 CHEMBL71733 0.353 0.003 CHEMBL3542314 | CHEMBL3542314 | |
| 0.058 | 0.214 | 0.174 | Toll-Like receptor 9 antagonist | 0.134 0.073 CHEMBL71733 0.174 0.049 CHEMBL3542314 | CHEMBL3542314 | |
| 0.007 | 0.173 | 0.048 | Histone deacetylase 10 inhibitor | 0.048 0.012 CHEMBL3542327 | CHEMBL3542327 | |
| 0.017 | 0.186 | 0.052 | CDK4/cyclin D inhibitor | 0.052 0.051 CHEMBL3542314 | CHEMBL3542314 | |
| 0.182 | 0.361 | 0.466 | Antiinflammatory | 0.353 0.17 CHEMBL3542327 0.466 0.103 CHEMBL3542314 | CHEMBL3542314 | |
| 0.014 | 0.194 | 0.124 | Bromodomain-containing protein 3 inhibitor | 0.124 0.004 CHEMBL3542314 | CHEMBL3542314 | |
| 0.007 | 0.198 | 0.045 | 5-Alpha-reductase inhibitor | 0.045 0.021 CHEMBL3542314 | CHEMBL3542314 | |
| 0.009 | 0.212 | 0.044 | Histone deacetylase class IV inhibitor | 0.044 0.016 CHEMBL3542327 | CHEMBL3542327 | |
| 0.009 | 0.212 | 0.044 | Histone deacetylase 11 inhibitor | 0.044 0.016 CHEMBL3542327 | CHEMBL3542327 | |
| 0.072 | 0.285 | 0.138 | Sphingosine 1-phosphate receptor 2 agonist | 0.138 0.033 CHEMBL71733 0.133 0.039 CHEMBL3542314 | CHEMBL71733 | |
| 0.034 | 0.263 | 0.111 | Viral attachment inhibitor | 0.111 0.017 CHEMBL3542327 | CHEMBL3542327 | |
| 0.008 | 0.248 | 0.075 | Oxytocin antagonist | 0.075 0.013 CHEMBL3542327 | CHEMBL3542327 | |
| 0.029 | 0.291 | 0.101 | Potassium channel large-conductance Ca-activated activator | 0.101 0.023 CHEMBL3542327 | CHEMBL3542327 | |
| 0.005 | 0.276 | 0.022 | Kainate receptor 3 antagonist | 0.022 0.008 CHEMBL3542327 | CHEMBL3542327 | |
| 0.11 | 0.389 | 0.397 | Apoptosis antagonist | 0.397 0.039 CHEMBL71733 0.368 0.048 CHEMBL3542326 | CHEMBL71733 | |
| 0.014 | 0.309 | 0.038 | Nicotinic acid receptor 1 agonist | 0.038 0.031 CHEMBL3542314 | CHEMBL3542314 | |
| 0.01 | 0.307 | 0.086 | Phosphodiesterase VII inhibitor | 0.086 0.021 CHEMBL3542326 | CHEMBL3542326 | |
| 0.036 | 0.342 | 0.059 | Prolactin release inhibitor | 0.059 0.057 CHEMBL71733 0.059 0.055 CHEMBL3542314 | CHEMBL3542314 | |
| 0.005 | 0.315 | 0.053 | Kainate receptor 4 antagonist | 0.053 0.006 CHEMBL3542327 | CHEMBL3542327 | |
| 0.025 | 0.336 | 0.106 | DNA intercalator | 0.09 0.086 CHEMBL71733 0.106 0.068 CHEMBL3542326 | CHEMBL3542326 | |
| 0.004 | 0.324 | 0.034 | Kainate receptor 5 antagonist | 0.034 0.008 CHEMBL3542327 | CHEMBL3542327 | |
| 0.025 | 0.355 | 0.115 | Telomerase inhibitor | 0.099 0.034 CHEMBL71733 0.115 0.028 CHEMBL3542326 | CHEMBL3542326 | |
| 0.02 | 0.362 | 0.1 | HIV-1 integrase inhibitor | 0.1 0.025 CHEMBL3542326 | CHEMBL3542326 | |
| 0.109 | 0.453 | 0.267 | Cyclophilin D inhibitor | 0.267 0.194 CHEMBL3542327 | CHEMBL3542327 | |
| 0.011 | 0.364 | 0.058 | CC chemokine 5 receptor antagonist | 0.058 0.028 CHEMBL3542327 | CHEMBL3542327 | |
| 0.012 | 0.366 | 0.184 | CC chemokine receptor antagonist | 0.184 0.013 CHEMBL3542327 | CHEMBL3542327 | |
| 0.006 | 0.366 | 0.166 | Dopamine D4 agonist | 0.166 0.009 CHEMBL3542327 | CHEMBL3542327 | |
| 0.015 | 0.392 | 0.087 | 5-Lipoxygenase inhibitor | 0.087 0.074 CHEMBL3542327 | CHEMBL3542327 | |
| 0.053 | 0.581 | 0.343 | Lipocortins synthesis antagonist | 0.343 0.014 CHEMBL3542326 | CHEMBL3542326 | |
| 0.021 | 0.549 | 0.12 | Cholinergic | 0.12 0.108 CHEMBL71733 | CHEMBL71733 | |
| 0.004 | 0.615 | 0.049 | Melatonin 2 agonist | 0.049 0.011 CHEMBL3542314 | CHEMBL3542314 | |
| 0.006 | 0.675 | 0.083 | Butyrylcholinesterase inhibitor | 0.083 0.079 CHEMBL71733 0.082 0.08 CHEMBL3542326 | CHEMBL71733 | |
| 0.008 | 0.681 | 0.03 | DNA polymerase III inhibitor | 0.03 0.015 CHEMBL3542314 | CHEMBL3542314 | |
| 0.005 | 0.804 | 0.263 | Protein-tyrosine phosphatase inhibitor | 0.263 0.028 CHEMBL3542327 | CHEMBL3542327 | |
| 0.004 | 0.841 | 0.228 | Protein-tyrosine phosphatase 1B inhibitor | 0.228 0.021 CHEMBL3542327 | CHEMBL3542327 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |